The QualityStocks Daily Stock List
- Acreage Holdings, Inc. (ACRGF)
- American Battery Metals Corporation (ABML)
- Celexus, Inc. (CXUS)
- Medicine Man Technologies, Inc. (MDCL)
- PureTech Health plc (PTCHF)
- US Nuclear Corp. (UCLE)
- Western Uranium and Vanadium Corp. (WSTRF)
- Adynxx, Inc. (ADYX)
- Nautilus Minerals, Inc. (NUSMF)
- Sun Pacific Holding Corp. (SNPW)
- Nexeon MedSystems, Inc. (NXNN)
- IGEN Networks Corp. (IGEN)
- Continental Energy Corp. (CPPXF)
- Ecosphere Technologies, Inc. (ESPH)
Acreage Holdings, Inc. (ACRGF)
New Cannabis Ventures, The Cannabis Investor, TipRanks, Street Insider, Investing News, Proactive Investors, Invrsting.com, MarketBeat, Market Screener, OTC Markets, TMXmoney, Dividend Investor, TradingView, Stockwatch, and InvestorsHub reported earlier on Acreage Holdings, Inc. (ACRGF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Acreage Holdings, Inc. is one of the largest vertically integrated, multi-state operators of cannabis licenses and assets in the United States. The Company owns licenses to operate or has management or consulting services or other agreements in place with license holders to assist in operations in 20 States (including pending acquisitions). Acreage Holdings has its corporate headquarters in New York, New York and the Company lists on the OTC Markets Group’s OTCQX.
The Company’s national retail store brand, The Botanist, debuted in 2018. The Botanist provides an immersive, educational hub for people who desire to live a balanced and socially responsible lifestyle. Acreage’s products are innovatively formulated to help consumers experience a more holistic path to health and wellness.
From seed to sale, Acreage Holdings focus is creating industry standards that deliver the highest quality products and experiences. Its business model includes Cultivation, Process Manufacturing, Dispensing, and Consumer Brands.
Along with the Botanist, Acreage has its Prime brand. This is a premier brand of medical cannabis, from seed to sale. Prime concentrates on advancing health and wellness and delivering top-quality, pesticide-free products designed for precise dosing and medicating.
Moreover, Acreage has its Live Resin Project brand. Live Resin Project offers an inventive line of vapes and concentrates crafted using unique extraction methods that use the whole cannabis plant. Furthermore, Acreage has its Natural Wonder brand. This is a lifestyle brand of quick-acting, discreet and effective breath sprays formulated with natural ingredients and combined with first-rate cannabinoids.
At the beginning of November, Acreage Holdings announced the grand openings of two The Botanist branded cannabis dispensaries in Ohio by its business partner Greenleaf Apothecaries, LLC. The new dispensaries are located at 3865 Lakeside Avenue East, Cleveland, Ohio, and 115 Vine Street, Columbus, Ohio.
Today, Acreage Holdings announced that on November 15, 2019, certain of its subsidiaries and Compassionate Care Foundation, Inc. (CCF), a New Jersey vertically integrated cannabis non-profit corporation, entered into a Reorganization Agreement, pursuant to which Acreage Holdings will acquire 100 percent of the equity interests in CCF, and then consolidate their financials. The closing of the transaction is subject to State approval. CCF’s vertically integrated operations include licenses for cultivation, manufacturing & processing, and three retail dispensaries.
Acreage Holdings, Inc. (ACRGF), closed Monday's trading session at $4.40, up 2.3256%, on 610,620 volume with 1,218 trades. The average volume for the last 3 months is 238,228 and the stock's 52-week low/high is $3.83999991/$30.00.
American Battery Metals Corporation (ABML)
Penny Stock Hub, Stock Tube, Last10k, Proactive Investors, Big News Network, OTC Markets, Stockwatch, Simply Wall St, Real Investment Advice, Mining Journal, Stockhouse, Investing.com, Mining Capital, and Investors Hangout reported beforehand on American Battery Metals Corporation (ABML), and today we report on the Company, here at the QualityStocks Daily Newsletter.
American Battery Metals Corporation is a premier battery metal exploration and development company. Its focus is on its Railroad Valley battery metal project in Nevada with the objective of becoming a significant domestic supplier of battery metals to the increasing electric vehicles (EV) and battery storage markets in the U.S.
American Battery Metals is based in Incline Village, Nevada. Its shares trade on the OTC Markets Group’s OTCQB. The Company was formerly known as Oroplata Resources, Inc. It changed its corporate name to American Battery Metals Corporation in May of 2019.
American Battery Metals, through its subsidiaries, engages in the exploration and development of lithium properties. The Company announced this past July that results of its first geophysical exploration program demonstrate that a large and undefined reservoir exists on its property in Railroad Valley, Nevada. The geophysical Magnetotelluric (MT) Survey was conducted over a square mile area by Zonge International of Reno, Nevada. Zonge has extensive experience in geophysical data acquisition and target identification on Lithium Exploration Projects.
The results of the geophysical survey indicate two large conductive zones located within the project area. "Conductive Zones" could indicate the presence of Lithium concentration in shallow clay deposits and in deeper Brine deposits. One of these conductive zones was earlier drill tested to a depth of 3,000 feet.
Last month, American Battery Metals released information about its Railroad Valley TW-1 drill project. The drilling and fluid sampling method chosen for well TW-1 was highly successful. The drill hole reached a depth of 3004 feet. This was 500 feet deeper than originally projected.
Composite drill cuttings yielded highly anomalous lithium values up to 148.5 ppm within parts of the Volcanic and Middle Sandstone areas. Another interval assayed as high as 276 ppm Li. The values are a positive indicator of the potential for higher values in sediments and groundwater in Railroad Valley.
Today, American Battery Metals announced that it attended the 2019 Benchmark Minerals Intelligence Minerals Week in Marina del Rey, California. Minerals Week is the premier lithium ion battery and electric vehicle supply chain event centered on the important battery raw materials of lithium, cobalt, nickel and graphite. American Battery Metals’ head of Business Development and Government Affairs, Mr. Doug Nickle, represented the Company at the 3-day event.
American Battery Metals Corporation (ABML), closed Monday's trading session at $0.036, up 2.8571%, on 1,254,921 volume with 64 trades. The average volume for the last 3 months is 849,941 and the stock's 52-week low/high is $0.028999999/$0.379000008.
Celexus, Inc. (CXUS)
OTC Markets, Investors Hangout, TradingView, InvestorsHub, Wallet Investor, Dividend Investor, Last10k, Stockwatch, TeleTrader, Street Insider, PR Newswire, Invest Tribune, Market Screener, Stockopedia, Simply Wall St, Stockhouse, and GlobeNewswire reported earlier on Celexus, Inc. (CXUS), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Celexus, Inc. is an acquisition, management and holding company for high-trajectory agritechnology businesses and farming technologies. The Company was formerly known as Telupay International, Inc. As of February 2019, Celexus agreed to acquire HempWave and operate it as a wholly-owned subsidiary. HempWave partners with farmers across the nation to grow, cultivate, and harvest commercial-grade hemp plants and seeds to produce medicinal grade cannabidiol (CBD oils) and other hemp by-products. Celexus lists on the OTC Markets’ OTCQB and the Company is Arizona based.
Celexus operates as an acquisition, management, and holding company for early stage businesses and technologies in the hemp industry. It works to bring to market the best, most valuable innovations in the thriving industrial hemp space. The Company is actively assessing new acquisition candidates throughout the agriculture industry.
Celexus’ aim is to control every aspect of the farming industry. This is from seeds to extraction and distribution. This eliminates reliance on third parties and ensures premier quality processes and production.
HempWave has acquired all five of the industrial hemp licenses available from the State of Arizona. This is licensure that makes HempWave one of the first vertically integrated hemp companies in Arizona. HempWave has also entered into agreements with four large-scale farming operations in Arizona. These agreements will allow it to grow and harvest industrial hemp on more than 600 acres in 2019. Its four initial commercial hemp farms will be based in Arizona's Gila River Valley, and in the cities of Eloy and Willcox.
HempWave is offering hemp seedlings and clones to farms in Texas. Presale opportunities are available to buyers immediately, with details to be determined when licensing starts for Texas growers sometime next year.
At the end of October, Celexus announced its new research and development (R&D) division. In association with small businesses and entrepreneurs, the Company is developing proprietary software utilizing blockchain algorithms specific to the complexities of hemp biomass transactions.
Additional technology in development includes drone mapping, soil nutrition, as well as data analytics, among others. The Company is investing in the technologies that will move agriculture, especially industrial hemp, into a growth market with far-reaching economic and environmental impact.
Celexus, Inc. (CXUS), closed Monday's trading session at $0.55, off by 8.3333%, on 12,910 volume with 8 trades. The average volume for the last 3 months is 2,619 and the stock's 52-week low/high is $0.207000002/$1.95299994.
Medicine Man Technologies, Inc. (MDCL)
Penny Stock Tweets, Cannabis Life Network, Uptick Newswire, MarketWatch, The Street, Daily Marijuana Observer, YCharts, New Cannabis Ventures, Investing Daily, Stockhouse, Technical420, Green Market Report, Morningstar, Barchart, Insider Financial, Simply Wall St, GuruFocus, PR Newswire, and MarketBeat reported beforehand on Medicine Man Technologies, Inc. (MDCL), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Medicine Man Technologies, Inc. is a vertically integrated cannabis operator. The Company provides consulting, cultivation supplies and equipment, retail pharma-grade products, and turnkey solutions for cannabis producers, processors, and retailers. It is taking advantage of its considerable expertise and intellectual property (IP) to vertically integrate into plant-touching cannabis operations. Medicine Man Technologies is based in Denver, Colorado and the Company lists on the OTCQX.
Medicine Man Technologies started 2019 with announcing the pending revenue positive acquisitions of Medicine Man Denver and MedPharm. Futurevision Ltd. (dba Medicine Man Denver) is a profitable operator with an anticipated $25M run rate for 2019. It opened its first store in 2009 and presently has four locations. It is a well-known industry leader in the cannabis business in the State of Colorado and has a large cultivation facility.
MedPharm is a fast-growing revenue positive pharmaceutical-grade cannabis operator expecting profitability in 2019. It cultivates, processes and formulates to pharmaceutical standards for medical and recreational users.
Fundamentally, Medicine Man Technologies is leveraging its knowledge and IP to vertically integrate retail, cultivation, formulation and distribution operations. The Company’s client portfolio includes active and past clients in 20 States and seven countries.
Medicine Man Technologies’ IP includes the ""Three A Light"" methodology for cannabis cultivation and pending acquisition candidate MedPharm's GMP-certified facility. This facility has the first cannabis research license to conduct clinical trials in the United States.
Medicine Man opened a retail dispensary in Longmont, Colorado, on February 20, 2019. The store opening comes after the Company’s January announcement of entering a binding agreement anticipated to lead to the near-term acquisition of Medicine Man by Medicine Man Technologies (MDCL). The new dispensary is strategically located on "Car Row" with auto dealerships close by, guaranteeing higher than normal foot traffic for retail sales.
Medicine Man Technologies has entered into binding term sheets to acquire some of the best-selling cannabis brands in the legal Colorado cannabis industry. This is a combination of pending transactions that spans 12 cultivation facilities (including Los Sueños Farms LLC, one of North America's largest sustainable cannabis farms); seven proprietary extraction facilities (including Purplebee's); seven manufacturers of infused products (including Medically Correct, one of Colorado's largest edible manufacturers; licensed producer of incredibles in Colorado, and creators of new brands Quiq and Nove); 33 strategically located retail dispensaries (including five Starbuds-branded dispensaries in Colorado); and a state-of-the-art manufacturing/research and development lab (MedPharm's Colorado facility has the first and only active cannabis research license in the State).
Medicine Man Technologies, Inc. (MDCL), closed Monday's trading session at $2.835, off by 3.5714%, on 67,979 volume with 187 trades. The average volume for the last 3 months is 80,910 and the stock's 52-week low/high is $1.05999994/$4.17000007.
PureTech Health plc (PTCHF)
Stock Gumshoe, OTC Markets, Macroaxis, Whale Wisdom, Real Investment Advice, Market Screener, YCharts, Dividend Investor, Wallet Investor, GuruFocus, Morningstar, Investors Hangout, Nasdaq, Seeking Alpha, Stockhouse, Dividend.com, and TMXmoney reported previously on PureTech Health plc (PTCHF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
PureTech Health plc is a clinical stage biotechnology company listed on the OTC Markets. It is discovering, developing and commercializing highly differentiated medicines for devastating diseases. These include intractable cancers, lymphatic and gastrointestinal diseases, central nervous system (CNS) disorders, and inflammatory and immunological diseases, among others. Incorporated in 2015, PureTech Health has its corporate headquarters in Boston, Massachusetts.
The Company established the underlying programs and platforms that have resulted in a considerable pipeline consisting of 24 product candidates and one product cleared by the FDA (Food and Drug Administration) that are being advanced internally or by its affiliates. PureTech Health’s focus is the Brain-Immune-Gut (BIG) axis. It is developing new categories of therapeutics through taking advantage of the science of the BIG axis.
The Company’s internal programs are centered on harnessing the lymphatic system and related immunology mechanisms for the treatment of cancer, immunological, lymphatic and CNS-related disorders. Regarding its ‘affiliate programs’, the affiliates include 13 clinical-stage product candidates, including one product cleared by the FDA and a second product candidate that has been filed with the FDA for review, and a number of other novel preclinical programs that have been developed in collaboration with some of the world's foremost scientific experts.
Today, PureTech Health noted that Karuna Therapeutics, Inc., an affiliate of PureTech Health, today announced results from its Phase 2 clinical trial of KarXT for the treatment of acute psychosis in patients with schizophrenia. In the clinical trial, KarXT demonstrated a statistically significant and clinically meaningful 11.6 point mean reduction in total Positive and Negative Syndrome Scale (PANSS) score versus placebo (p < 0.0001) and demonstrated good overall tolerability. In addition, a statistically significant reduction in the secondary endpoints of PANSS-Positive and PANSS-Negative scores were also observed (p < 0.001).
Daphne Zohar, Founder and Chief Executive Officer of PureTech Health, said, “These impressive results are another important validation of PureTech’s innovation engine that has generated highly differentiated platforms to address serious diseases, leading to 24 product candidates, including 14 clinical stage and one recently FDA cleared product.
It is very exciting to see Karuna reach this important milestone with its lead candidate KarXT that originated at PureTech. KarXT is now being advanced by one of the leading CNS drug development teams and has the potential to be the first novel therapeutic approach in decades to treat psychosis in patients with schizophrenia and Alzheimer’s disease.”
PureTech Health plc (PTCHF), closed Monday's trading session at $3.80, up 35.7143%, on 316,780 volume with 79 trades. The average volume for the last 3 months is 1,897 and the stock's 52-week low/high is $2.00999999/$4.01999998.
US Nuclear Corp. (UCLE)
Energy Central News, TipRanks, YCharts, Investing.com. StockPulse, Stock News Now, Market Screener, Seeking Alpha, Stockhouse, Simply Wall St, Stockopedia, Morningstar, and GlobeNewswire reported earlier on US Nuclear Corp. (UCLE), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
US Nuclear Corp. is a leader in radiation detection. The Company develops, manufactures, and sells radiation detection and measuring equipment around the world. US Nuclear has 100 plus years of experience providing quality Chemical Radiation Detection and Monitoring Instrumentation. OTCQB-listed, US Nuclear is headquartered in Canoga Park, California.
Through three operating divisions (Technical Associates (TA)), Overhoff Technology (OTC), and Electronic Control Concepts (ECC), the Company supplies first-rate instrumentation to any industry utilizing radionuclides. These industries include nuclear power plants, national laboratories, government agencies, homeland security, military, and universities and schools. Furthermore, industries include research companies, hospitals, medical and dental centers, energy companies, weapons facilities, first responders, local governments, and manufacturing plants.
US Nuclear provides measurement instrumentation for the nuclear energy industry and for developing technological processes including Fusion, Thorium and Molten Salt (MSR) reactor technologies domestically and internationally.
American and International customers include United States Government Agencies, the U.S. Military, Homeland Security, National Laboratories, Universities, Hospitals, nuclear reactor facilities in the USA, China, Canada, South Korea, Argentina, Russia, and others.
US Nuclear also engages in Product Development. Its newest product development is the incorporation of radiation and chemical sensors with drone mounted platforms. Its strategic partnership with FlyCFam UAV provides a comprehensive package to a customer that flies in all-weather, heavy winds, and with a heavy payload. This provides the opportunity to fly many sensors at one time with real-time wireless download.
US Nuclear has a strategic alliance agreement with QYSEA Technology. This agreement is to market, build, sell, and service Industrial Underwater Robot Sensor Systems in the U.S. and worldwide.
US Nuclear has joined the fight against widespread toxic PFAS Chemical Pollution in air and water. Its portable air sampler, Model PFAS-100-AIR, employs a high-volume pump to trap airborne PFAS over time on a special activated-charcoal filter.
After collection, the filter is sent into a lab, where it will be analyzed to tell the airborne PFAS concentration for that area. The Company’s portable water sampler, Model PFAS-100-H20, operates in a like capacity, sampling a source of water utilizing a special reverse osmosis process to obtain a small, concentrated volume of PFAS in water that is sent to the lab for measurement.
US Nuclear Corp. (UCLE), closed Monday's trading session at $1.05, up 8.2474%, on 30,720 volume with 35 trades. The average volume for the last 3 months is 12,643 and the stock's 52-week low/high is $0.202000007/$2.8499999.
Western Uranium & Vanadium Corp. (WSTRF)
Zacks, Market Seat, OTC Markets, Dividend Investor, Energy and Capital, Streetwise Reports, TradingView, Junior Mining Network, GlobeNewswire, Vanadium Price, Stockhouse, Proactive Investors, Investor Intel, Stockwatch, Morningstar, Market Screener, and Wallmine reported earlier on Western Uranium & Vanadium Corp. (WSTRF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.
OTCQX-listed, Western Uranium & Vanadium Corp. is a uranium and vanadium conventional mining company. It focuses on low cost near-term production of uranium and vanadium in the western United States, and also the development and application of ablation mining technology. Ablation Mining Technology (AMT) is a proprietary process that improves efficiency and lessens costs for sandstone hosted deposits. Western Uranium & Vanadium has offices in Toronto, Ontario and Nucla, Colorado.
The Company is among the largest U.S. Uranium and Vanadium in-situ resource holders. It has a total uranium resource of 70,000,000 lbs. +/- and a total vanadium resource of 35,000,000 lbs. +/- grading between 1.4-2.2 percent. Western Uranium & Vanadium’s near-term production strategy includes concentrating on previously producing mines for low capex (capital expenditures), existing infrastructure, as well as permitting.
In addition, the Company’s strategy includes defining and developing a high-grade vanadium resource at the Sunday Mine Complex (SMC). Moreover, its strategy is also to deliver SMC ore samples to many potential customers and joint venture (JV) partners, and baseload SMC production with a vanadium ore concentrate agreement. Western Uranium & Vanadium’s strategy is also to pursue vanadium development at the Sage Mine Project. It will also work to pursue uranium contracts and development at prices above current price levels.
This past September, Western Uranium & Vanadium announced that the Sunday Mine Complex (SMC) Vanadium Project continues to deliver favorable results. The initial sampling from the face of the mine workings showed V2O5 grades ranging from 3 percent to 14 percent. Large quantities of ore were mined to ascertain expected production grades.
Twelve samples were analyzed from the four mines from 12 areas mined. The average grade of vanadium was 3.15 percent. The Company noted in September that development drilling has been taking place to expand the mine production areas. Development drilling was continuing and mining of ore had started. Ore will be stockpiled in the mines until the requirements of the Colorado Division of Reclamation, Mining and Safety (CDRMS) are completed.
Western Uranium & Vanadium Corp. (WSTRF), closed Monday's trading session at $0.60838, off by 0.265574%, on 6,000 volume with 4 trades. The average volume for the last 3 months is 22,521 and the stock's 52-week low/high is $0.494100004/$2.20000004.
Adynxx, Inc. (ADYX)
TipRanks, TMXmoney, Xconomy, Street Insider, Investing.com, BioCentury, Stockhouse, Market Screener, TradingView, Stockopedia, Dividend Investor, GlobeNewswire, and PR Newswire reported previously on Adynxx, Inc. (ADYX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
A clinical stage biopharmaceutical company, Adynxx, Inc. focuses on bringing to market novel, disease-modifying products for the treatment of pain and inflammation. The Company’s pipeline includes brivoligide, a Phase 2 drug candidate intended to address postoperative pain, and AYX2, a pre-clinical candidate intended to treat chronic syndromes of pain, including inflammatory and neuropathic pain. Fundamentally, Adynxx is a leader in transcription factor decoy technology. Established in 2007, Adynxx has its corporate headquarters in San Francisco, California.
The Company has worked since its founding to discover and develop transcription factor decoys to modify the course of pain, to collaborate with discovery partners, and to identify in-licensing opportunities with transformative therapeutic profiles to build a pipeline in pain and inflammation.
Adynxx is collaborating with twoXAR to use twoXAR’s artificial intelligence-driven drug discovery platform. This is to identify endometriosis treatments. In addition, Adynxx is evaluating in-licensing opportunities with transformative therapeutic profiles to treat pain and inflammation.
The AYX platform employs a proprietary technology of non-opioid, disease-modifying transcription factor decoys. AYX decoys are short DNA molecules, or oligonucleotides. They selectively inhibit transcription factors controlling the genes involved in the maintenance of pain. Therefore, a single administration of an AYX decoy generates a strong, long-term reduction of pain and associated clinical benefits.
Clinical studies suggest that a single administration of brivoligide at the time of surgery can safely lessen pain for weeks, speed up the time to attain mild pain and considerably decrease the need for opioid use during recovery specifically in patients at greater risk of experiencing increased and prolonged pain following surgery.
Recently, Adynxx announced that Mr. Gregory J. Flesher, Chief Executive Officer (CEO) at Novus Therapeutics, Inc. (NASDAQ: NVUS), was appointed to the Adynxx Board of Directors. Since May of 2017, Mr. Flesher has served as the CEO and a member of the Board of Directors of Novus Therapeutics, a specialty pharmaceutical company centered on developing products for patients with disorders of the ear, nose and throat.
For Q2 of 2019, Adynxx reported a Net Loss of $4.7 million, versus a Net Loss of $1.4 million for the same period in 2018. Research and development expenses were $1.9 million in Q2 of 2019, versus $0.6 million for the same period in 2018. This increase was mainly because of $0.7 million in connection with start-up activities related to Adynxx's planned Phase 2 ADYX-005 total knee arthroplasty and Phase 2 ADYX-006 mastectomy clinical trials and $0.7 million related to the initiation of drug supply manufacturing with Avecia, partially offset by a decrease in salaries and benefits from the resignation of an employee and other minor cost changes.
Adynxx, Inc. (ADYX), closed Monday's trading session at $0.80, up 52.3519%, on 5,709 volume with 13 trades. The average volume for the last 3 months is 2,079 and the stock's 52-week low/high is $0.525099992/$31.4400005.
Nautilus Minerals, Inc. (NUSMF)
OTC Markets, PennyStockTweets, Stockhouse, Equities, Marketwired, InvestorsHub, Barchart, Junior Mining Network, The Street, MarketWatch, and YCharts reported previously on Nautilus Minerals, Inc. (NUSMF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Nautilus Minerals, Inc. is the first company to explore the ocean floor for polymetallic Seafloor Massive Sulphide (SMS) deposits. Nautilus is developing a production system utilizing existing technologies adapted from the offshore oil and gas industry, dredging and mining industries to enable the extraction of these high-grade SMS systems on a commercial scale.
Nautilus Minerals has offices in Brisbane, Australia; Canada; and in Kavieng, New Ireland, Papua New Guinea, and Nuku'alofa, Tonga, South Pacific.
A seafloor resource exploration business, Nautilus explores and develops the ocean floor for copper, gold, silver, and zinc SMS deposits. Furthermore, the Company explores for manganese, nickel, copper, and cobalt nodule deposits. Nautilus has its copper-gold project named Solwara 1. It is under development in the territorial waters of Papua New Guinea (PNG).
The Solwara 1 deposit sits on the seafloor at a water depth of about 1600 meters. Solwara 1 contains a copper grade of approximately 7 percent. This compares with land-based copper mines, where the copper grade today averages 0.6 percent.
Gold grades of substantially more than 20 g/tonne have been recorded in some intercepts at Solwara 1. The average grade is roughly 6 g/tonne. Moreover, the Company holds highly prospective exploration acreage in the western Pacific (granted and under application), and in international waters in the Central Pacific.
Nautilus Minerals is currently negotiating the terms of an agreement with arm's length third parties. This would involve the establishment of a new joint venture company (the Vessel JV) to be owned by the third parties and Nautilus’ subsidiary, Nautilus Minerals Niugini Limited (NMN).
The purpose of the Vessel JV would be to fund the acquisition of the Production Support Vessel (PSV) that Nautilus had previously arranged to be obtained through MAC Goliath Pte Ltd (MAC) and the integration expenses of installing the mining equipment on the PSV. The Vessel JV would own and operate the fully integrated PSV.
Recently, Nautilus Minerals announced that it and Deep Sea Mining Finance Ltd. agreed to extend the maturity date of the existing secured loan facility that is currently due on February 8, 2019, for 28 days ending on March 8, 2019.
Nautilus continues to seek short and long term funding solutions. This is while assessing its options, including different restructuring options. Negotiations with various third parties continue.
Nautilus Minerals, Inc. (NUSMF), closed Monday's trading session at $0.0058, up 132.00%, on 3,411,498 volume with 73 trades. The average volume for the last 3 months is 208,181 and the stock's 52-week low/high is $0.000001999/$0.069499999.
Sun Pacific Holding Corp. (SNPW)
MarketWatch, Marketwired, Zacks, 4-Traders, and Investorx reported previously on Sun Pacific Holding Corp. (SNPW), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Sun Pacific Holding Corp., by way of its subsidiaries, provides solar bus stops, solar trashcans and “street kiosks” using its innovative advertising offerings that provide state and local municipalities with cost efficient solutions. The Company’s subsidiaries include Sun Pacific Power Corp., Street Smart Outdoor Corp., Sun Pacific Security Corp., and National Mechanical Group. A green energy, OTCQB-listed company, Sun Pacific is based in Manalapan, New Jersey.
Sun Pacific specializes in solar and waste to energy technologies. Subsidiary Sun Pacific Security will offer customers the latest in security automation systems. This subsidiary enables one to view secure, live and recorded video of their property at any time on their computer, smartphone or tablet. Sun Pacific Security has not commenced operations in the security sector. It is reviewing plans to provide customers the latest in security automation systems.
Subsidiary Sun Pacific Power builds next generation solar panels and lighting products made primarily in the United States. Sun Pacific Power has eight global manufacturing and assembly locations. These include five in the U.S.
Sun Pacific Power provides solar powered bus shelters, solar powered LED trash bins, solar products and lighting products. The Smart Solar Bus Shelter provides LED lighting for increased visibility and security and other technological additions not previously available.
Street Smart Outdoor is Sun Pacific’s street furniture outdoor advertising subsidiary. Currently, it is maintaining advertising space on greater than 1,000 bus shelter faces, bus benches, smart solar digital shelters and solar trash bins.
Sun Pacific is integrating blockchain technology into its renewable energy business model and strategy designed to improve grid management efficiency for solar and wind farms. The Company earlier signed a Letter of Intent (LOI) to buy 60 acres of land to build a solar and wind farm, where electricity generation will be optimized via a combination of both energy sources. The Company plans to take the project one step closer to the future through using blockchain technology to monitor the new grid, load balance, and increase the life of electrical equipment.
Sun Pacific Holding Corp. (SNPW), closed Monday's trading session at $0.0067, up 45.6522%, on 49,260,889 volume with 538 trades. The average volume for the last 3 months is 33,303,256 and the stock's 52-week low/high is $0.0003/$0.029799999.
Nexeon MedSystems, Inc. (NXNN)
NetworkNewsWire, Taglich Brothers, YCharts, Stockwatch, Wallet Investor, Street Insider, Penny Stock Hub, Awesome Penny Stocks, TipRanks, Stockhouse, Stockopedia, Zacks, Barchart, and InvestorsHub reported previously on Nexeon MedSystems, Inc. (NXNN), and we also report on the Company, here at the QualityStocks Daily Newsletter.
Nexeon MedSystems, Inc. centers on providing innovative neurostimulation products. Its focus is on providing neurostimulation products that improve the quality-of-life of patients suffering from debilitating neurological diseases. Nexeon MedSystems has offices in Dallas, Texas and Liege, Belgium (Nexeon MedSystems Belgium SPRL). The Company’s shares trade on the OTC Markets Group’s OTCQB.
Nexeon MedSystems Belgium, SPRL (NMB) has acquired Medi-Line. This is a Belgian medical device manufacturer. Currently, Medi-Line serves numerous medical device customers in 16 nations. It has multi-year contracts with Fortune 500 companies.
MedSystems is an international bioelectronics medical device company. It has developed and commercialized a neurostimulation system. The system can be used to treat a variety of neurological diseases. Neurostimulation systems are used to restore neuronal function. The Company’s SYNAPSE™ device is the platform used in a process called Deep Brain Stimulation (DBS).
The platform acts like a brain pacemaker sending electrical pulses to specifically targeted areas in the brain. SYNAPSE™ reduces shortcomings in present-day DBS therapy. It enables the detection, measurement, as well as collection of brain signals, while simultaneously providing targeted DBS therapy. Furthermore, it provides directional stimulation that limits side effects.
Additionally, manifold stimulation frequencies permit increased therapy range. As well, rechargeable means a greater range of available therapies and rechargeable enables one surgery in comparison to many.
This past November, Nexeon MedSystems announced that it received grant matching funds from the Puerto Rico Science, Technology, and Research Trust. The National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH) earlier awarded a $830,000 grant to Nexeon’s wholly-owned subsidiary, Nexeon MedSystems Puerto Rico Operations Corporation (NMPROC, Nexeon PR).
This funding will go to support the development of novel cloud-based software to improve programming for deep brain stimulation. The National Institutes of Health announced funding of over 200 new awards, totaling greater than $220 million, by way of the Brain Research Advancing Innovative Neurotechnologies (BRAIN) Initiative.
Nexeon MedSystems, Inc. (NXNN), closed Monday's trading session at $4.50, up 171.0843%, on 260 volume with 2 trades. The average volume for the last 3 months is 146 and the stock's 52-week low/high is $1.10000002/$6.50.
IGEN Networks Corp. (IGEN)
NetworkNewsWire.com, MarketWatch, InvestorsHub, Marketwired, OTC Markets, Information Vine, Business Insider, Stock Press Daily, The Street, and Barchart reported on IGEN Networks Corp. (IGEN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
IGEN Networks Corp. is a foremost innovator of cloud-based and Internet of Things (IoT) automotive solutions for the protection and management of mobile assets. The Company provides peace-of-mind to automotive consumers and their families via direct access to IoT cloud-based services, which include Stolen Vehicle Protection, Real-time updates on asset health and Driver Behavior. OTCQB-listed and incorporated in 2006, IGEN Networks has its head office in Murrieta, California.
The Company provides vehicle tracking and recovery solutions to the automotive dealership industries in the U.S. IGEN Networks serves the automobile industry through vehicle security services, lot management services, and driver behavior services.
IGEN Networks enables automotive dealer channels to provide new products, create additional revenue streams, as well as keep their customers. The Company provides peace-of-mind to consumers through providing direct access to vehicle status and driver behavior. The Company also enables insurance companies to decrease their rating errors through offering consumers discounted premiums in return for access to vehicle and driver behavior data.
This past October, IGEN Networks announced the launch of Medallion GPS™. Medallion GPS™ is a new, easily installed, direct-to-consumer solution. It combines vehicle agnostic hardware with cloud based smartphone software. This system provides automotive aftermarket customers with a new standard in stolen vehicle recovery support, vehicle systems alerts, driver behavior monitoring and GPS tracking capabilities, in addition to other features.
Recently, IGEN Networks announced the filing of its Q3 2017 financial results. The Company increased year-to-date Revenue 26 percent to 1.04 million, boosted by growing adoption of its mobile asset tracking platforms. It grew the subscriber base 264 percent year-over-year, to over 31,000 assets at September 30, 2017.
IGEN increased deferred revenue 146 percent, to $182,000. The Company increased gross margin to 39.2 percent through the first nine months, versus 36.8 percent in the previous year period. It reported a Net Loss of $662,000 year-to-date, excluding stock based compensation expenses, versus $551,000 in the previous year nine-month period.
IGEN Networks Corp. (IGEN), closed Monday's trading session at $0.0377, up 52.6316%, on 5,000 volume with 2 trades. The average volume for the last 3 months is 58,342 and the stock's 52-week low/high is $0.020999999/$0.087499998.
Continental Energy Corp. (CPPXF)
TopPennyStockMovers, Streetwise Reports, and Agoracom reported previously on Continental Energy Corp. (CPPXF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Continental Energy Corp. is an emerging developer of conventional and alternative energy capacity integrated with upstream and downstream petroleum supply within the Republic of Indonesia. Listed on the OTC Markets, the Company’s commitment is to developing hybrid renewable electrical power generation capacity and profitably operating mini-grid distribution networks in the huge, under-served markets of the fast-growing economies encircling the Indian Ocean Rim.
Established in 1984, Continental Energy is headquartered in Vancouver, British Columbia. The Company previously went by the name Continental Copper Corp. It changed its corporate name to Continental Energy Corp. in October of 1997.
The Company’s core competency exists in Indonesia. It has 30 years of experience in Indonesia. This has given Continental Energy the business relationships and local operating experience necessary to capitalize on the rising energy demand in this country.
In addition, Continental Energy has its business combination with the Ruaha River Power Company. This business combination provided instant entry into Tanzania. This is where the best-in-Africa commercial incentives for small scale renewable energy developers are in place to foster new supply of power to off-grid communities.
Recently, Continental Energy announced the filing on SEDAR of its audited consolidated financial statements and its management discussion and analysis for its Fiscal 2017 year ended June 30, 2017. Continental had a Loss from Operations of $439,606 during Fiscal 2017 versus a Loss from Operations of $473,289 during Fiscal 2016. This represents a decrease of $33,683, mainly because of lower professional fees and share-based payments.
The Company had a loss per share of $0.00 in both 2017 and 2016. Continental’s administrative costs were lower by $14,428 in 2017 versus 2016. This was chiefly because of reduced professional fees: 2017 - $376,842; and 2016 - $391,270. As at the end of this Fiscal Year 2017, Continental Energy’s Working Capital deficit was $1,721,256 versus a Working Capital deficit of $1,282,380 at the end of Fiscal 2016.
Continental Energy Corp. (CPPXF), closed Monday's trading session at $0.012, up 100.00%, on 128,496 volume with 7 trades. The average volume for the last 3 months is 4,800 and the stock's 52-week low/high is $0.0026/$0.029999999.
Ecosphere Technologies, Inc. (ESPH)
TheMicrocapNews, PennyStocks24, Buzz Stocks, Penny Pick Finders, PennyStockProphet, SmallCapVoice, Wall Street Resources, Planet Penny Stocks, SecretStockPromo, and StockOnion reported earlier on Ecosphere Technologies, Inc. (ESPH), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Ecosphere Technologies, Inc. is a development and Intellectual Property (IP) licensing company. It develops environmental solutions for global water, energy, industrial, and agricultural markets. The Company helps industry increase production, lessen costs, and protect the environment through a portfolio of inventive, patented technologies and exclusive and nonexclusive licensing opportunities across a wide spectrum of industries and applications globally. Ecosphere Technologies is based in Stuart, Florida.
Ecosphere has a wide-ranging portfolio of patented clean technologies. These can be purchased and licensed for use in large-scale and sustainable applications across industries, nations, and ecosystems. The Company’s technologies include the Ecos PowerCube®, the Ecos GrowCube™, and Ozonix®.
The Ecosphere technologies and products are available via many brands and subsidiaries. These include Sea of Green Systems, Ecosphere Development Company, and Fidelity National Environmental Solutions. The Company’s goal is to help clean energy producers’ gain more control over their water resources, quality, and completion costs through providing effective mobile water recycling solutions.
The Ecosphere Ozonix® Technology provides a chemical-free alternative to high-volume water recycling for a varied range of applications. These range from the oil & natural gas industry and mining to agriculture and municipal wastewater treatment. The oil and natural gas industry is successfully using Ecosphere Technologies’ patented Ozonix® technology to treat and recycle the water used in oil and natural gas well drilling and completion programs.
The Ecos PowerCube® is the world’s largest, mobile, solar-powered generator. It runs on high power photovoltaic panels. These panels extend from its container combined with an easy to set up wind turbine. Energy is stored in onboard batteries.
The Ecos GrowCube® is a state-of-the-art, turn-key, fully-automated "greenhouse". It uses hydroponic growing techniques to maximize the amount of crop production possible in a given footprint. The Ecos GrowCube® incorporates Ecosphere’s patented Ozonix® water treatment technology. In addition, Ecosphere has its Ozonix Sentinel. This is the world's first line of water treatment vessels for cleaning up endangered rivers and lakes.
Sea of Green Systems (SOGS), a subsidiary of Ecosphere Technologies, announced in January 2017 the launch of its SOGS-650X, Full Spectrum LED Growing Light. This light was developed to provide growers with an engineered solution to maximize vegetative growth and flower production for the indoor agriculture and legal marijuana industries.
The SOGS-650X can produce greenhouse-like conditions through providing an average 25 DLI (Daily Light Integral) during the Vegetative and Flowering Cycles, with about 450-650 uMols and 700-900 uMols at the plant canopy during their respective growth cycles. Sea of Green Systems (SOGS) sells high-tech growing equipment, lighting solutions, and nutrients to the Precision Agriculture industry.
Recently, Sea of Green Systems announced that its sublicensee in the agricultural industry, Gulf Coast Organics (GCO), signed an agreement with Wedgworth's, Inc., to be the exclusive distributor in Florida for its Amp Agronomy™ plant nutritional line. Wedgworth's is recognized as Florida's largest custom fertilizer dealer since 1932. Wedgworth's provides custom blended agricultural plant nutrient products across Florida to help farms grow and prosper. CAVISONIX®, developed by SOGS and Ecosphere Technologies, utilizes ultrasonic cavitation to treat fertilizers for increased plant availability.
Ecosphere Technologies, Inc. (ESPH), closed Monday's trading session at $0.0015, up 50.00%, on 103,500 volume with 4 trades. The average volume for the last 3 months is 141,166 and the stock's 52-week low/high is $0.000000999/$0.012699999.
The QualityStocks Company Corner
- Predictive Oncology (NASDAQ: POAI)
- Sigma Labs Inc. (NASDAQ: SGLB)
- HTC Extraction Systems (TSX.V: HTC)
- ChineseInvestors.com (CIIX)
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF)
- Wonderfilm Media Corporation (TSXV: WNDR) (OTC: WDRFF)
- Spectrum Global Solutions, Inc. (SGSI)
- Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)
- The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
- Sharing Services Global Corporation (SHRG)
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF)
- Sugarmade, Inc. (SGMD)
- SinglePoint, Inc. (SING)
- LiveWire Ergogenics Inc. (OTC: LVVV)
Predictive Oncology (NASDAQ: POAI)
Predictive Oncology (NASDAQ: POAI) on Friday announced its financial results for the quarter ended September 30, 2019 and provided a business update. To view the full press release, visit http://nnw.fm/MxP4S.
Predictive Oncology (POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for the cancer patients of today and tomorrow. The company has several tools that support its mission of bringing precision medicine to the treatment of cancer.
Through its subsidiaries, Predictive Oncology’s portfolio of assets includes the following:
- A database of clinically validated historical and outcome data from patient tumors
- An in-house Clinical Laboratory Improvement Amendments (CLIA)-certified lab
- A “smart” patient-derived tumor profiling platform
- An in-house bioinformatics artificial intelligence (AI) platform
- A new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options
- An FDA-approved fluid collection and disposal system
Using these resources, and in collaboration with key players in the pharmaceutical, diagnostic and biotech industries Predictive Oncology is working to determine the best pathways for more individualized and effective cancer treatment.
Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.
Helomics applies artificial intelligence to its rich data gathered from the company’s trove of more than 150,000 tumors to personalize cancer therapies for patients as well as drive the development of new targeted therapies in collaborations with pharmaceutical companies. This database, the largest of its kind in the world, is comprised of ovarian, head and neck, colon and pancreas tumors. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.
In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.
TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory without the use of rats or mice, allowing for the identification of biomarkers indicative of cancer. This methodology “fools” the tumor into thinking it is still in the body. As a result, the tumor reacts as it naturally would, thereby increasing the accuracy of the biomarker. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and helps categorize an individual patient’s heterogeneous tumor samples to enable development of patient-specific treatment options.
Skyline Medical’s patented, FDA-cleared STREAMWAY® System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.
The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.
Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.
Precision medicine has become the holy grail of cancer therapeutics. Data driven predictive models of tumors and their responses are critical in both new drug development and individualized patient treatment. The race has begun to model various tumors, which takes 5 to 7 years of clinical evaluation to establish historical and outcome data.
Predictive Oncology enjoys significant competitive advantage. The company already has a vast historical collection of tumors and related data, plus the ability to obtain existing associated outcome data. While others wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine to reality. Predictive Oncology already has the clinical data, including how a tumor responded to certain drugs, an in-house bioinformatics AI platform, and only needs to do the tumor sequencing. The significance is underscored by the collaboration with UPMC Magee-Women’s Hospital, designed to reveal which mutations responded to which drug then develop powerful predictive models for future testing and treatment.
Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.
CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.
Gerald Vardzel, President of Helomics, has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches. His Go-To-Market expertise includes equity financing, strategic planning, market intelligence, M&A, and new market development in both start-up and established settings including fortune 500 market leaders. He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel also has significant experience designing and implementing sales and marketing programs tailored not only to expand market share, but to empirically assess client satisfaction, strengthen business processes, and maximize profitability. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions. Furthermore, as an executive affiliate to the healthcare industry, he routinely consults for several small-to-mid sized private equity firms advising on, in part, the feasibility of acquisition targets. Mr. Vardzel graduated from the University of Pittsburgh.
Dr. Mark Collins, Chief Information Officer of Helomics, has held multiple executive roles in a variety of discovery, informatics and bioinformatics functions within global pharma, and founded three startup software companies in the machine learning and drug discovery space. In 2001, Dr. Collins worked for Cellomics (now part of Thermo Fisher Scientific), where he played a pivotal role in establishing the High-Content Cell Analysis market, building and commercializing several key informatics and bioinformatics products. After leaving Thermo Fisher, Dr. Collins developed and commercialized informatics solutions for clinical and translational research, specifically in the specimen tracking, omics data management and NGS analysis space, through key roles at BioFortis, Global Specimens Solutions and Genedata. Dr. Collins received his undergraduate degree in Applied Science from the University of Wolverhampton, UK and his Ph.D. in Microbiology from the University of Surrey, UK.
Predictive Oncology (POAI), closed Monday's trading session at $3.90, up 1.4304%, on 23,621 volume with 170 trades. The average volume for the last 3 months is 16,234 and the stock's 52-week low/high is $3.31999993/$8.50.
- Predictive Oncology Inc. (NASDAQ: POAI) Reports Q3 Results, 58% Revenue Increase
- Predictive Oncology Inc. (NASDAQ: POAI) Harnessing the Power of Artificial Intelligence to Improve Clinical Outcomes
- Predictive Oncology Inc. Reports Q3 Results; Revenues Increase 58%
Sigma Labs Inc. (NASDAQ: SGLB)
Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D printing industry, on Thursday reported its financial and operational results for the third quarter ended September 30, 2019. Among other highlights, the company reported revenue for the third quarter of $171,003, a significant increase compared to $128,593 for the same period in 2018. To view the full press release, visit http://nnw.fm/3gqLY.
Sigma Labs Inc. (SGLB) is the only provider of in-process quality-assurance software to the commercial 3D printing metal industry that enables operators of machines making 3D metal parts to offset emerging quality problems, sustain part quality, and avoid rejects. Sigma’s software is the singular solution that enables both real-time, in-process detection of quality control manufacturing irregularities for critical metal parts and then provides the operator the actionable information needed to adjust and mitigate the developing anomaly. Sigma Labs’ software represents a paradigm shift in the quality control process for the manufacture of 3D printed metal components. The nascent 3D metal printing industry is on the verge of radically altering the speed and technical complexity of manufactured parts. Further, it makes possible just-in-time availability of critical components – all at reduced cost, time, waste and weight. 3D printing, heralded as the fourth industrial revolution in manufacturing, will only truly surpass traditional techniques when the additive manufacturing industry moves from “post process” quality control to “in process” quality assurance.
For the industry to move from prototype manufacturing of critical components to economically viable commercial production, the 3D metal printing industry must find ways to dramatically increase production speed and quality yields, and to dramatically decrease the excessive cost of quality control. To achieve these prerequisites and move 3D metal printing into the mainstream, parts must be inspected and certified during the manufacturing process rather than after. Parts in the production process that are developing signs of quality control problems must be identified in real-time and alerts must be issued. The problem, along with the solution, must then be communicated to the machine operator to implement repairs.
Revolutionizing Additive Manufacturing
Sigma Labs, with its PrintRite3D® brand, has established a new benchmark in the development and commercialization of real-time computer aided inspection (“CAI”) solutions. Sigma Labs resolves the major roadblocks and costly quality control challenges that impede the 3D manufacture of precision metal parts. The company’s breakthrough computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance during production, uniquely allowing errors to be corrected in real-time.
Sigma Labs was founded in 2010 by a team of Los Alamos National Labs scientists and engineers to develop and commercially license advanced metallurgical products for the military ordinance, dental implants, and then for additive manufacturing (3D printing). After assessing 3D metal printing technology and the costly, inconsistent quality control issues, Sigma Labs concluded that the enormous potential of 3D metal printing could only scale up if in-process quality-assurance tools were developed to observe, manage and control the manufacturing complexities in such a manner that reliability and repeatability of very high precision quality metal parts could be achieved in the process. Sigma Labs’ patented and third-party validated software has achieved these objectives and now delivers the critical elements needed to unleash the promise of 3D metal printing.
Sigma Labs’ products and services are engineered, manufactured and qualified for use in the highly demanding and hyper precise production environments of the aerospace, defense, transportation, oil and gas, biomedical and other precision-dependent industries.
Additive metal manufacturing combines multiple processes and parts into one single 3D printed part. Due to variances in the additive manufacturing process, parts of consistent quality currently can’t be reliably produced in either large or small quantities without substantial postproduction inspection and rejection costs. Parts are inspected after production using CT scans and other means, so the manufacturer doesn’t know until the very end which of the finished parts meet design specifications. This means lost time, lost profits and inability to economically scale up production.
Sigma Labs solves this problem with its patented, in-process quality control technology that informs operators and engineers how to improve both the manufacturing process and quality by capturing meaningful data about inconsistencies in real-time. Sigma Labs is also partnering with OEMs, working toward the visionary introduction of revolutionary closed-loop control that will bypass the machine operator and automatically make in process corrections by reducing machine variations.
Sigma Labs’ next generation technology gives manufacturers the ability to make fast, virtual real-time adjustments so that each finished part is uniform and within critical specifications, thereby improving production quality, decreasing end-users’ risks and waste, and increasing profits and speed to market. Sigma Labs’ PrintRite3D® IPQA Software monitors and assesses the quality of each production part in the 3D additive manufacturing process – layer by layer, and in real-time. This has never been available until now.
Sigma Labs maintains a strong intellectual property portfolio consisting of trade secrets, process know-how and 34 patents either granted, pending or awaiting pre-publication around the globe. These patents encompass the fundamental technologies underlying Sigma Labs’ melt pool process control, data analytics, anomaly detection, signature identification, and future “closed-loop control” of 3D metal printing.
Providing advanced quality assurance software to the commercial 3D printing industry is currently a $1.4 billion addressable market expected to grow to $3.9 billion by 2023. Integrating Sigma Labs’ groundbreaking software helps arm the industry with a necessary catalyst to help enable and optimize the fourth industrial revolution in manufacturing.
Sigma Labs’ global client base includes 23 installations across 19 different users. Tier-1 OEM enterprises and end-users such as Siemens, Honeywell, Pratt & Whitney and others are currently evaluating PrintRite3D® for production lines.
John Rice, CEO and chairman of the board of directors, has extensive experience as a CEO, lead negotiator, turnaround expert, business financier and crisis management executive/consultant. Prior to becoming chair and CEO of Sigma Labs, he was the CEO of a successful turn-around of a Coca-Cola Bottling Company. Rice has led a variety of companies in diverse business sectors and worked on a host of products and technologies including design and manufacture of high-end jet engine test equipment for the U.S. Airforce, chaff dispensers for F16s, software for modeling naval exercises, software for controlling warehouse distribution systems, medical radioisotopes, cancer detection, and cybersecurity. He is an honor’s graduate of Harvard College.
Darren Beckett, CTO, has over 20 years of experience in the semiconductor industry, including Intel Corporation, where he held various technical and managerial positions. His expertise in process engineering for advanced manufacturing technology includes statistical process control for fabrication of semiconductor devices.
CFO Frank D. Orzechowski also serves as treasurer, principal accounting officer, principal financial officer and corporate secretary. He has more than 30 years of distinguished financial and operational experience. Orzechowski began his career at Coopers & Lybrand in 1982, received his CPA certification in 1984, and received his Bachelor of Science in Business Administration with a major in accounting from Georgetown University in 1982.
Ronald Fisher, vice president of business development, is leading the commercialization of PrintRite3D® 5.0. Fisher is a mechanical engineer with hands-on experience in quality, manufacturing and product development. He has distinguished himself as a lead sales and marketing officer as well as a chief operating officer most recently before joining Sigma in technology startup that grew from market entry to successful exit by merger-acquisition.
Sigma Labs Inc. (SGLB), closed Monday's trading session at $0.89, up 12.6582%, on 117,503 volume with 357 trades. The average volume for the last 3 months is 162,117 and the stock's 52-week low/high is $0.451099991/$2.46000003.
- Sigma Labs Inc. (NASDAQ: SGLB) Transforming the Creation of Critical 3D Metal Printing Components
- Sigma Labs, Inc. (NASDAQ: SGLB) Posts Q3 2019 Financial Results
- Sigma Labs Reports Third Quarter 2019 Financial Results, Beats Revenue Projection
HTC Extraction Systems (TSX.V: HTC)
HTC Extraction Systems (TSX.V: HTC) was featured today in the 420 with CNW by CannabisNewsWire. Georgia’s key leaders have launched a program providing the state’s 15,000 registered patients with medical marijuana seven months after the Governor approved the program. Licensing for companies seeking to grow and sell medical marijuana oil would be granted by a seven-member commission, which was appointed by Governor Kemp, House Speaker David Ralston, and Lt. Governor Geoff Duncan. According to Georgia state laws, marijuana oil can be used to treat Parkinson’s disease, severe seizures, and terminal cancer as well as other ailments.
HTC Extraction Systems (TSX.V: HTC) has developed and optimized proprietary technologies designed for biomass extraction, distillation and purification of ethanol and ethanol-based solvents used for the hemp biomass and cannabidiol (“CBD”) industry, as well as gas and liquid extraction. HTC’s extraction & purification systems are engineered to large-scale to reduce capital and operating costs while delivering superior performance measured by reduced energy usage, lowered emissions and improved quality of the product produced.
Advanced Extraction Technologies
For more than 14 years, HTC has developed and optimized proprietary technology and purification systems used for biomass, gas and liquid extraction. These technologies include:
- LCDesign® – Low-cost design for modular gas, liquid and biomass extraction systems optimizes plant design, thus reducing capital and operating costs.
- PDOEngine™ – Software-based design algorithms accurately model and simulate gas, liquid and biomass extraction processing.
- Delta Solvents™ – Custom-designed, ethanol-based solvent mixtures and additives that optimize production and reduce costs. Technology development is being conducted at HTC’s sponsored research facilities at the University of Calgary.
Delta Purification® Technology
HTC’s patented Delta Purification® technology will purify, recycle and reuse the extraction ethanol used in the CBD extraction process while managing and reducing any CBD waste losses through the re-extraction of all wastes collected from the purified ethanol. Current and new technologies include:
- Delta CBD Reclaiming System: Reclaiming and purifying ethanol for use in CBD extraction from biomass. Reduces required heat to prevent damage of the chemical attributes of the CBD molecule, allowing extracted CBD to meet food-grade targets for human consumption.
- Delta Solvent Reclaiming System: Reclaiming and purifying ethanol-based solvents, such as single, mixed and formulated amines, for use in natural gas processing and post-combustion CO2 capturing processes.
- Delta Glycol Reclaiming System: Reclaiming and purifying glycols, such as mono-ethylene glycol and tri-ethylene glycol for use in natural gas dehydration processes.
Hemp Biomass and Tolling Contracts
HTC has entered into a hemp biomass tolling agreement for the 2019 crop year involving a supply of hemp biomass from a hemp grower in Saskatchewan, Canada. The hemp grower utilizes five varieties of Health Canada-approved cultivars as the genetic foundation. HTC will process and extract CBD FSO distillate from the hemp biomass. As a tolling fee payment, HTC will receive a percentage of the extracted CBD FSO distillate for its processing, extraction, purification and distillation services.
Additional hemp biomass tolling contracts with producers and hemp biomass providers are being negotiated in the U.S. for the 2020 hemp crop growing year. HTC will provide “local-to-grower” drying-to-biomass storage capability and transportation of dried biomass to an HTC, location to be determined, future US based, extraction facility. HTC is also in negotiation with a 60,000-acre, recognized Canadian farm leader, who is a significant hemp biomass producer, for a similar hemp biomass tolling contract.
Large users of ethanol and solvents for plant oil extraction demand reduced capital and operating costs. HTC’s re3™ (reclaim, recycle, reuse) technology can save up to 30% of the required fluid costs. The increasing cost of new extraction ethanol, combined with the cost of used ethanol disposal, creates a unique opportunity whereby the re3™ technology will create cost savings, while meeting environmental responsibilities.
The growth of ethanol and CO2 used in CBD production has created a new demand for reliable commercial scale ethanol reclaimer systems. The Delta Purification® ethanol system meets this new demand.
Sales and Offtake Agreements
HTC intends to leverage its relationship with its related entity, Purely Canada Foods™, to provide sales and distribution for its Ingredient CBD market under the brand of Purely Canada Hemp™, Purely Canada CBD™, Purely Canada Cannabinoids™. Purely Canada Hemp™ will develop risk managed multi-year ingredient supply contracts with its existing and new Global Food, Beverage and Animal Food Industry Customers.
HTC has focused the Canadian implementation of its BOOM (build, own, operate and maintain) extraction tolling strategy on a location near Regina, Saskatchewan. HTC is currently constructing a 19,000-square-foot GMP Euro compliant extraction tolling facility on six acres of land that will include biomass processing, extraction, implementation of DeltaSolv™ technologies and Delta Purification® systems, distillate and refining equipment, laboratory quality control and testing operations, and on-site office and admin facilities.
Chairman, CEO and Director Lionel Kambeitz is a recognized professional in business development and international business relations. He has played a founding role in many other Canadian and U.S.-based companies. Kambeitz has executive experience in a variety of industries including energy, agriculture, food production engineering, and manufacturing.
Jeff Allison, Senior Vice President, Chief Financial Officer and Director, has over 20 years of experience in corporate finance and business development. Prior to joining HTC in 2005, Allison as Vice President assisted with the founding and setup of CUCORP Financial Services in Saskatchewan.
HTC Extraction Systems (TSX.V: HTC), closed Monday's trading session at $0.275, up 1.8519%, on 47,000 volume with 14 trades. The average volume for the last 3 months is 121,788 and the stock's 52-week low/high is $0.079999998/$1.24.
- 420 with CNW – Georgia’s Medical Marijuana Program Kicks into High Gear
- HTC Extraction Systems (TSX.V: HTC) Positioned to Capitalize on Market Forecasted to Reach $22 Billion by 2022
- HTC Extraction Systems (TSX.V: HTC) Hemp Biomass Extraction Facilities Take Shape
ChineseInvestors.com (OTCQB: CIIX), an established financial news and investment portal as well as a leading industrial hemp retailer for the Chinese-speaking community, today announced that its CEO, Warren Wang, was interviewed on The RedChip Money Report television program. To view the full press release, visit http://cnw.fm/crRX2. Also today, the company announced today that its CEO, Warren Wang, was interviewed on The RedChip Money Report television program. Watch the interview now: https://youtu.be/erFNIohNhD8.
Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.
Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.
At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.
CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.
The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.
Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.
In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.
ChineseInvestors.com (CIIX), closed Monday's trading session at $0.2501, up 0.04%, on 21,945 volume with 22 trades. The average volume for the last 3 months is 44,532 and the stock's 52-week low/high is $0.165000006/$0.654999971.
- ChineseInvestors.com Inc. (CIIX) CEO Featured in RedChip Money Report Interview, Describes Tremendous Opportunity in China’s CBD Cosmetics Market
- ChineseInvestors.com CEO Explains Why CBD Cosmetics Business Set for Big Growth in China in Exclusive Interview
- ChineseInvestors.com Inc. (CIIX) to Focus on Core Business, Hemp-Infused/CBD Products in 2020
Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF)
Siyata Mobile (TSX.V: SIM) (OTCQX: SYATF) today announced its receipt of a $950,000 purchase order for its Uniden(R) UV350 from a U.S. distributor servicing cellular carriers, first responders and commercial fleets. To view the full press release, visit http://nnw.fm/LCj9W.
Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) is a leading global developer and provider of Push-to-Talk Over Cellular ("PTT/PoC") systems for enterprise customers. The company specializes in connected vehicle products for professional fleets and markets its products under the Uniden® Cellular brand.
Since its inception in 2012, Siyata has amassed a customer base that includes cellular operators, commercial vehicle technology distributors, and fleets of all sizes in Canada, the U.S., Europe, Australia and the Middle East.
Recognized by the Toronto Venture Stock Exchange in 2018 as a Venture Top 50 Company, Siyata aims to deliver the highest quality and most technologically advanced mobile communication devices for global corporate workforces, fleets, homes and buildings.
The company has long been an industry pioneer, delivering the world's first 3G connected vehicle device as well as the world's first 4G/LTE vehicle mounted smartphone for First Responders and commercial fleets and vehicles.
Siyata is headquartered in Montréal, Québec, Canada.
Siyata's suite of technology includes numerous PTT and legacy devices, as well as cellular boosters designed to improve cellular signals in corporate warehouses, government embassies, retirement home campuses, banks and manufacturing plants.
The company's flagship product, the Uniden UV350, is the world's first vehicle-mounted 4G/LTE smartphone with crystal clear quality, carrier grade PTT, voice, text, video and data applications built into a single device. Specifically designed for First Responder and commercial fleet vehicles, the UV350 runs on cellular LTE networks that provide nationwide and global coverage, replacing traditional single purpose two-way radios that require a monthly fee and limited network coverage.
The Uniden UV350 is currently available through Bell Mobility, Canada's largest LTE network and PTT community. Expanding its availability, Siyata is completing network approval with two North American Tier 1 operators to launch the UV350 in the U.S. in 2019.
CEO and Chairman Marc Seelenfreund is the founder of Siyata. He is also the founder of Siyata's parent company, Accel Telecom, an Israel-based company that specializes in importing and distributing innovative cellular and IP devices to fixed line operators and mobile providers within Israel. Prior to establishing Accel, Seelenfreund was a vice president at Sunrise Corporation in New York where he focused on financing publicly traded technology companies. Seelenfreund has a law degree from Bar Ilan University, is a board member at Israel's leading private university, and has served as an officer in the Israel Defense Forces.
Glenn Kennedy, vice president of sales, has over 25 years of sales experience in the telecommunications industry. Prior to joining Siyata in 2016, Kennedy managed sales nationally for Motorola Canada, HTC Communications Canada, and Sonim Technologies. He holds a bachelor's degree in honors business administration from the Richard Ivey School of Business at the University of Western Ontario.
CFO Gerald Bernstein, a professional chartered accountant, has spent 20 years focusing on private equity financing and tax efficient corporate structuring in multi-jurisdictional arenas. He holds a bachelor's degree of commerce as well as a graduate diploma in public accountancy from McGill University. Bernstein has been a member of the Canadian Institute of Chartered Accountants since 1987.
Gidi Bracha, Vice President of Technology, has served in this position since 2011 and spearheaded the development of both the Truckfone, Voyager and UV350. Bracha served in various key positions at Cellcom, Israel's leading cellular provider, including head of car mobility products and director of type approvals. Bracha served as an engineer technician in the Anti-Aircraft division of the Air Force in the Israel Defense Forces and holds a bachelor's degree in engineering and business management from the University of Derby.
Siyata Mobile Inc. (SYATF), closed Monday's trading session at $0.2448, up 3.9049%, on 149,146 volume with 34 trades. The average volume for the last 3 months is 62,264 and the stock's 52-week low/high is $0.198500007/$0.446249991.
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Receives $950K Purchase Order from Top US Distributor
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Integrates with CrisisGo to Bring Nation’s Yellow School Bus Drivers an Instant Emergency Communications Solution
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Receives $800K in Purchase Orders for In-Vehicle Cellular Devices
Wonderfilm Media Corporation (TSXV: WNDR) (OTC: WDRFF)
The explosive birth of home-access Internet a generation ago has now produced a growing giant of a child in the form of video streaming services – the global video on demand segment of the industry alone was valued at $28.9 billion in 2017 and is expected to reach $89.3 billion by 2026 according to analysts at Maximize Market Research (http://nnw.fm/LtKb7). British Columbia-based film production house Wonderfilm Media Corporation (TSX.V: WNDR) (OTCQB: WDRFF) is an up-and-coming developer of original content with established box office talent that stands to benefit from the demand for new content that streaming’s rise portends.
Wonderfilm Media Corporation (TSXV: WNDR) (OTC: WDRFF) main business is the worldwide production of high-quality feature films and episodic television. The Wonder?lm team includes Hollywood veterans who have packaged, produced and delivered several profitable recent films, including “BlacKkKlansman,” “Get Out” and “The Hurt Locker.” Having these individuals on the Wonderfilm team demonstrates the company’s proven access to Academy Award-quality films and upside.
Wonder?lm maintains a continuing $58 million annual production slate to meet the constant and growing need for content worldwide. The company’s risk-averse production process results in predictable and consistent revenue streams.
Soaring demand for content from streaming providers is fueling industry growth. The global media and entertainment market is expected to grow from $1.9 trillion in 2017 to $2.4 trillion in 2022, a five-year CAGR of 4.4%.
The company recently formed Wonderfilm Global, an international film and television sales and distribution joint venture that is expected to generate significant incremental revenue.
Wonderfilm has strong relationships throughout the entertainment industry, which enables cost-effective production budgets and in-demand content creation.
Management Team with Proven Track Records
Kirk Shaw: Over 240 movies and seven television series to his credit. Headed up Canada’s largest independent film and television production company, attaining $100 million revenue two years straight with 8% EBITDA.
Dan Grodnik: Founded Mass Hysteria Entertainment, a publicly traded company, and became its chairman/CEO. Produced over 50 feature films, including “Bobby,” the 2006 Robert Kennedy biographic film.
Shaun Redick & Yvette Yates: $300 million+ USD total production budgets to date with a combined 175 award wins/355 nominations, including 10 Oscar nominations. In 2017 and 2018, they produced two of the most successful Hollywood films of those years: “Get Out” ($255 million USD gross revenue) and “BlacKkKlansman” ($100 million USD gross revenue). Scheduled to produce two to three films per year for Wonderfilm, with the first release slated for October 2020. Committed to the 4% challenge to give more women and women of color the opportunity to direct.
Jeff Bowler: 2017 Emmy Award-winning producer. Vice president of acquisitions and production for The Exchange, one of the top film sales and finance companies in the world. Bowler is the executive for Wonderfilm Global distribution.
Bret Saxon: Through his company, TMP Inc., Saxon created M&A deals worth over US$750 million across 113 countries. Produced several feature films and made-for-television movies, including Wonderfilm’s 2019 movie “Zombie Tidal Wave” for NBC/Universal’s SYFY.
17-Title Movie Slate — Greenlit
Wonderfilm currently has 17 films greenlit with combined budgets totaling $58 million. Wonderfilm production stars include: John Travolta, Nicolas Cage, Guy Pearce, Ryan Phillippe and Anne Heche, to name a few.
Some of the company’s most notable greenlit projects include the horror film “Amityville 1974,” slated for theatrical release in October 2020, and the action film “Inside Game” starring Tyrese Gibson, which will be released to theaters in fall 2020.
The company is also actively developing a number of other new IP projects, including a dramatic biographic feature titled “Life and Times of Steve McQueen,” a film adaptation of the bestselling novel “Merchant of Death” and a television series headed by “CSI: Crime Scene Investigation” creator Anthony Zuiker.
Potential for Breakout Success
Wonderfilm movies have the potential for millions of dollars in revenue from the kind of breakout success generated by films like “Saw” and “Get Out,” which would propel Wonderfilm and its revenue streams to a new level. Wonderfilm has several potential breakout films in its development/production queue.
Note: Potential breakout films are not factored into company’s revenue projections.
Base Hits and Home Runs
In tandem with its slate of high-profile films, Wonder?lm continues to finance, produce and deliver many profitable low-risk, lower-budget films that are base hits. Shaun Redick is a home run hitter, and his upcoming Wonderfilm projects are anticipated to be home run hits for the company, while base hits such as “Zombie Tidal Wave” provide a consistent source of revenue.
Recent Industry Breakout Films Include:
- SAW – $1.2 million budget = $103.9 million in sales
- Pulp Fiction – $8 million budget = $212 million in sales
- My Big Fat Greek Wedding – $5 million budget = $250 million in sales
- Lost in Translation – $4 million budget = $120 million in sales
- Get Out – $4.5 million budget = $255.5 million sales (Shaun Redick)
Note: Revenue from most of Wonderfilm’s current slate will be recorded on the books in 2020 or 2021.
Recent Wonderfilm Releases
- Aug. 17, 2019: Co-produced with NBC/Universal, “Zombie Tidal Wave” premièred on the SYFY channel to strong ratings.
- Aug. 29, 2019: “The Fanatic” starring John Travolta opens in U.S. theaters.
- Sept. 5, 2019: “Tammy’s Always Dying” premiers at Toronto Film Festival.
- Nov. 8, 2019: “Primal” starring Nicolas Cage opens in U.S. theaters.
Wonderfilm Global Distribution
At the 2019 Cannes Film Festival, Wonderfilm officially launched Wonderfilm Global, a new film, television and media foreign sales/distribution joint venture with 101 Films and Paul McGowan.
Wonderfilm acquired 51% ownership in the joint venture structure and immediately began attaching its own productions to Wonderfilm Global. The joint venture represents a significant opportunity for Wonderfilm, changing how the company does business.
The intention behind Wonderfilm Global is to keep distribution margins in-house that previously went to other companies. Since most Wonderfilm movies are relatively low-risk and easy to sell because they feature desirable cast and genre, third-party distribution companies were previously earning approximately 10%, plus expenses, on Wonderfilm movies without any level of risk. Now, revenue is generated through presales of Wonder?lm projects and, at times, third-party films. The average Wonder?lm movie is pre-sold for $5million, garnering $500,000 to $750,000 per sale as a commission. These commissions now stay in-house with Wonder?lm Global, and the company expects to sell 10 to 12 third-party films between fall 2019 and fall 2020, generating roughly $6 million in commission income.
A further revenue source is generated from theatrical sales through a 50/50 upside split once the minimum sales threshold is met.
Wonder?lm Global has offices in Vancouver, Beverly Hills, London, Ireland, Seoul and China.
Wonderfilm Business Model
Wonderfilm productions are structured to begin generating a return to the company as soon as the camera starts rolling.
Return Before a Film is Delivered: Producer fee line items are included in each production budget. These range from $50,000 to $500,000, depending on the total budget, and are paid to Wonderfilm most commonly on the first day of principle photography.
Distribution: Wonderfilm Global charges sales and distribution fees within each production budget to cover its presale costs.
Note: Wonderfilm’s productions are all structured to minimize risk by matching budget to funds available.
Return After a Film is Delivered: Unsold presale territories are countries or territories left off of a film’s presale list, either for strategic reasons or because the broadcaster/distributor is waiting to see the completed film. These outside-the-budget distribution sales become Wonderfilm profit centers.
Sales overages once contracted presale threshold is surpassed.
The company’s film library grows with each new production, adding to future sales revenue. Depending on the agreement, exploitation rights for future worldwide sales return to Wonderfilm four or seven years after delivery. As of October 2019, Wonderfilm’s growing film library comprises 18 titles for future exploitation.
Note: The nature of the film business is that box office revenue lags production up to a couple of years.
$50 Million Wonderfilm Production Fund (WPF):
Wonderfilm is in the process of raising $50 million to establish a Wonderfilm Production Fund (WPF). WPF is designed to consolidate traditional production financing models into a single diversified, asset-backed debt instrument.
The WPF is a highly specialized investment vehicle with noncorrelated market returns normally reserved for institutional banks and specialty lenders, and it would pay 8% interest directly from each Wonderfilm movie or series budget and not from corporate funds. These same interest payments are already added to each production budget, as the company currently closes a separate financing for every film. The WPF would significantly streamline Wonderfilm’s production rate, adding revenue more quickly and broadening the yearly production slate.
For fund investors, the WPF is a dedicated production-financing vehicle designed to offer a risk-moderated approach to investing in film finance. The managed process provides structure and reassurance that are normally experienced only when working with an institutional lender that has a dedicated staff and resources.
All projects being financed are for Wonderfilm productions, with the fund collateral fully secured by receivables, including presale contracts, government incentives, or a guarantee from Wonderfilm for any unsecured amounts as may be permitted.
Wonderfilm Media Corporation (OTC: WDRFF), closed Monday's trading session at $0.1412, up 0.141844%, on 1,050 volume with 2 trades. The average volume for the last 3 months is 43,421 and the stock's 52-week low/high is $0.075099997/$0.504400014.
- Wonderfilm Media Corporation’s (TSX.V: WNDR) (OTCQB: WDRFF) Production Star Rising with Low-Risk Budget Model, Boom in Streaming Services
- Wonderfilm Media Corp.’s (TSX.V: WNDR) (OTCQB: WDRFF) Latest Theatrical Premiere Features Steven Seagal, DMX and Johnny Messner in “BEYOND THE LAW”
- Wonderfilm Media Corp. (TSX.V: WNDR) (OTCQB: WDRFF) CEO Featured in OTCQB Podcast
Spectrum Global Solutions, Inc. (SGSI)
Spectrum Global Solutions, Inc. (OTCQB: SGSI), a leading single-source provider of next-generation communications network infrastructure and maintenance solutions, today announced the closing of the previously disclosed acquisition of WaveTech GmbH (“WT” or “WaveTech”). To view the full press release, visit http://nnw.fm/YCn82.
Spectrum Global Solutions, Inc. (SGSI) is a leading single-source provider of end-to-end, next-generation wireless and wireline network infrastructure services and staffing solutions to the service provider (carrier) and corporate enterprise markets across the United States, Canada, Puerto Rico, Guam and the Caribbean. Spectrum Global Solutions provides services directly to carriers, aggregators, utilities, enterprise, Project Management Organizations (PMO) and Original Equipment Manufacturers (OEM) clientele through the following subsidiaries:
- AW Solutions, Inc. and AW Solutions Puerto Rico, LLC – Provides best-in-class communications infrastructure deployment services to carriers, OEMs, PMOs, utilities and enterprise clients by offering discrete and full turnkey service solutions for wireless and wireline clientele. AW Solutions holds professional engineering licenses in all contiguous states and in the District of Columbia and Hawaii; the Canadian provinces of British Columbia, Quebec, Ontario, Alberta and Newfoundland and Labrador; in Puerto Rico, Guam and the U.S. Virgin Islands.
- ADEX Corporation and ADEX Puerto Rico, LLC – An international service organization providing turnkey services and staffing solutions to telecommunications carriers and enterprise clients. Since 1993, ADEX has been assisting telecommunications companies throughout the project life cycle of any network deployment. ADEX and its service capabilities extend from the most basic installation functions to the most advanced engineering disciplines for today and tomorrow’s communications networks. Headquartered in Atlanta, Georgia, ADEX employs technical professionals and provides infrastructure services worldwide via domestic and international locations.
- Tropical Communications, Inc. – A state licensed electrical and underground utility contractor headquartered in Miami, Florida, providing all types of communications and infrastructure facility structured wiring services and solutions since 1984.
Through its subsidiaries, Spectrum Global Solutions is a comprehensive single-source provider for professional services and solutions for the development, deployment and maintenance of wireless/Distributed Antenna System (DAS)/small cell/wireline and fiber networks and infrastructure. The company’s services range in scope from a single activity to multiyear, multi-region, large-scale turnkey development contracts with a deepening pool of international, national, regional and local projects. Spectrum Global Solutions has completed more than 150,000 project activities on wireless, DAS, wireline and fiber networks across the United States utilizing licensed professional engineers, project managers, technicians and general contractors.
Growth projections for the telecom industry show a high growth cycle 2018 through 2025 with a four-fold increase in domestic mobile data traffic and up to $150 billion in fiber investment over the next 5-7 years (Deloitte, 2017). The worldwide explosion of smart phones, tablets and BYOD by customers demanding rapid deployment of new apps, private networks with better coverage and enhanced capacity provides a compelling enterprise opportunity market. The imminent rollout of 5G next generation networks, IOT (Internet-Of-Things) technology deployments, the FirstNet national public safety system, small cell/network densification, Dish Network Deployment, fiber and infrastructure network builds for backhaul and expanded deployments, new FCC spectrum auctions and upgrades to 4G, DAS and small cell networks are contributing to a projected $157 billion in U.S. telecommunication carrier capital expenditures by 2021.
CEO Roger Ponder has served as a director of Spectrum Global Solutions since April 2017. Ponder served as President/CEO of Summit Capital Advisors, LLC, and Summit Broadband, LLC a provider of consulting services to private equity and institutional banking entities in the telecommunications, cable and media/internet sectors. He also served as a member of the board of directors of InterCloud Systems, Inc. and served as its Chief Operating Officer from November 2012 to March 2015. Prior to that Ponder retired from Time Warner Kansas City Division as President/CEO. Ponder brings extensive business development, strategic planning and operational experience to the Company.
Keith Hayter is President of Spectrum Global Solutions and has served as a director of the Company since April 2017. Hayter has also served as the Chief Executive Officer and President of AW Solutions Inc. and AW Solutions Puerto Rico LLC since November 2006. He was Vice President and General Manager of Alcoa Wireless Services from 2001-2006. Hayter served in both the U.S. and British armies and brings extensive multi-national experience in the start-up, development, management and growth of companies in the telecommunication, engineering and construction industry.
Spectrum Global Solutions, Inc. (SGSI), closed Monday's trading session at $0.039, up 8.3093%, on 38,898 volume with 11 trades. The average volume for the last 3 months is 191,551 and the stock's 52-week low/high is $0.014999999/$0.449999988.
- Spectrum Global Solutions Announces Closing of WaveTech GmbH Acquisition
- Spectrum Global Solutions Inc. (SGSI) Set to Profit as 5G Rollout Nears
- Spectrum Global Solutions Inc. (SGSI) Adds $2.5 Million in New Contracts to $137 Million Opportunity Pipeline
Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)
Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) was featured today in a publication from CBDWire, examining how cannabidiol (CBD) is a cannabis extract with remarkable medicinal properties, and for the past few years, it has kept the world enthralled. It is often confused for THC (delta-9 tetrahydrocannabinol), the component responsible for cannabis’s famous high, but CBD is non-psychoactive, and it doesn’t make users high. Instead, the compound acts as a potent and versatile medicine, working against a variety of conditions ranging from anxiety and high blood pressure to chronic pain and rare childhood epilepsies.
Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary DehydraTECH™ technology for improved taste, rapidity and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.
Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECH technology to improve taste, remove odor and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada and the United States. Lexaria has also developed its own hmep-oil brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea and supplements. These brands include ViPova™, TurboCBD™ and ChargD+™.
Virtually unique across both the hemp and the cannabis industries, Lexaria has successfully entered into a R&D and product development partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Only a small handful of hemp or cannabis-related companies have achieved formal relationships with Fortune 500 industry leaders, demonstrating the wide applicability of Lexaria’s technology.
In June 2019, building on its original 2015 independent, third-party laboratory in vitro lab experiments, which confirmed the absorption levels of cannabidiol (“CBD”) into human intestinal cells rose by 499% through the utilization of the DehydraTECH technology, Lexaria completed a series of animal studies using an enhanced formulation of its DehydraTECH technology. The results of the animal studies using the enhanced DehydraTECH formulation showed an increase of CBD delivery into the blood when compared to generic industry MCT coconut-oil formulations by 811%. In addition, the animal studies also showed delivery of 1,937% more CBD into animal brain tissue after 8 hours using the enhanced DehydraTECH technology when compared to generic industry MCT coconut-oil formulations.
Lexaria also has completed the first phases of its collaborative research program with the Canadian government’s National Research Council (the “NRC”) under which several studies were designed to optimize Lexaria’s DehydraTECH technology, enabling delivery of API’s within foods, beverages, capsules and other ingestible formats. These studies investigated the lipophilic active agent classes including cannabinoids, vitamins, NSAIDs and nicotine using advanced analytical techniques, including mass spectrometry and nuclear magnetic resonance testing, with the results of the studies confirming that Lexaria’s DehydraTECH technology did not create any covalent-bonded new molecular entity (“NME”). Whenever an NME is created, regulatory bodies such as FDA and Health Canada routinely require extensive health, safety and efficacy studies prior to that product’s release into the marketplace. That the NRC program failed to find evidence of an NME suggests products utilizing the DehydraTECH technology may require a less burdensome regulatory pathway.
Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: hemp/CBD; pharmaceutical; cannabis; and nicotine. In August 2019, Lexaria was issued its cannabis research and development licence from Health Canada which will allow Lexaria to continue its further investigations in-house of its DehydraTECH technology in connection with cannabinoids, along with ongoing work with vitamins, NSAIDs, PDE5-inhibitors, nicotine and other molecules.
Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the August 2019, the company’s patent portfolio includes ~60 patent applications filed and pending in more than 40 countries around the world; and 16 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally by the end of 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others. Lexaria’s granted patent portfolio related to cannabinoid delivery is one of the largest in the world.
Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology to third-partners and has signed licensing agreements with start-up companies as well as with a Fortune 100 industry leader. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods and other relevant skillsets.
Lexaria Bioscience Corp. (LXRP), closed Monday's trading session at $0.48, off by 2.1407%, on 115,811 volume with 66 trades. The average volume for the last 3 months is 91,096 and the stock's 52-week low/high is $0.399800002/$1.6875.
- Hemp Researcher Files Billion Dollar Claim Against County in California
- Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Appoints Strategic Advisor, Advances Tech Platform as Alternative to Smoking and Vaping
- Lexaria Announces Closing of Non-Brokered Private Placement
The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1)today announced that its wholly-owned subsidiary, Blissco, has launched a new full-spectrum CBD oil, Pūr Dew. With the Pūr Dew CBD oil launch, Supreme Cannabis diversifies its product offerings, which currently include dry flower from 7ACRES and high-THC cannabis oil from KKE. To view the full press release, visit http://cnw.fm/9nttB. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. Georgia’s key leaders have launched a program providing the state’s 15,000 registered patients with medical marijuana seven months after the Governor approved the program.
Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”
Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.
In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.
“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”
The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.
Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.
7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.
Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.
Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.
To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.
Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.
Supreme Cannabis Company Inc. (OTC: SPRWF), closed Monday's trading session at $0.4697, off by 10.9573%, on 896,075 volume with 625 trades. The average volume for the last 3 months is 540,401 and the stock's 52-week low/high is $0.449999988/$1.7888.
- Supreme Cannabis Company Inc.’s (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Blissco Launches New, Full-Spectrum CBD Oil, Pur Dew
- 420 with CNW – Georgia’s Medical Marijuana Program Kicks into High Gear
- Cannabis Weekly Round-Up: Quarterly Updates Rock Market
Sharing Services Global Corporation (SHRG)
No industry is failing faster than retail, according to a 2018 report by Harvard Business Review (http://nnw.fm/vnXq9). Companies such as Sears, Toys R Us, Kmart and Payless seem to be echoing this idea as they shut their doors. According to the report, even those whose doors have stayed open are seeing stagnant sales. But is the retail industry actually failing, or is the way forward simply changing? That’s the question Sharing Services Global Corporation (OTCQB: SHRG) is answering.
Sharing Services Global Corporation (SHRG), headquartered in Plano, Texas, is a diversified holdings company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRG has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth.
Sharing Services Inc. subsidiaries include:
- A growing international network of home-based entrepreneurs, called “Elepreneurs”
- Growing selection of health and wellness products dedicated to elevating the well-being of all people
- Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
- Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
- Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
- Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness
Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.
“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”
The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.
Nearly 1,000 people attended Sharing Services Global Corporation ’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders – Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.
“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”
Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.
The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services Global Corporation , and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.
John “JT” Thatchwas appointed president and chief executive officer of Sharing Services Global Corporation , at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.
Sharing Services Global Corporation (SHRG), closed Monday's trading session at $0.11305, off by 9.56%, on 11,570 volume with 3 trades. The average volume for the last 3 months is 34,749 and the stock's 52-week low/high is $0.090000003/$0.3944.
- Sharing Services Global Corporation (SHRG) Leading the Way Forward in World of Changing Needs for Consumers, Workers
- Sharing Services Inc. (SHRG) Achieves Record Revenues During Q1 2019
- Sharing Services Global Corporation (SHRG) Reshaping Growing Industry to Meet Evolving Needs of Today’s Thriving Entrepreneurs
IONIC Brands Corp. (CSE: IONC) (OTC: IONKF)
IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) was featured today in the 420 with CNW by CannabisNewsWire. Cannabidiol (CBD) is a cannabis extract with remarkable medicinal properties, and for the past few years, it has kept the world enthralled. It is often confused for THC (delta-9 tetrahydrocannabinol), the component responsible for cannabis’s famous high, but CBD is non-psychoactive, and it doesn’t make users high.
IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) is a national cannabis holding company building a multistate portfolio of award-winning premium and luxury brands in the cannabis space. Established in 2015, IONIC Brands has demonstrated its ability to expand and operate multiple cannabis concentrate consumer brands in leading markets across the western United States, with current operations in Washington, Oregon, California and Nevada. The company continues to strategically expand nationwide to remain a leader of the highest-value segments in the cannabis market.
With a focus on quality, responsibility and respectability, IONIC’s product lines are pioneering the changing landscape of cannabis consumption. The company’s refinement practices are a result of a passionate commitment to craft the finest, small-batch cannabis oils and cannabis concentrates in the world – without glycols, glycerins or additives.
IONIC’s Certified Clean program verifies that every product leaving the company’s facilities meets or exceeds state mandates on pesticide testing. The testing is conducted by individually testing every batch which ensures and enhances trust and transparency. IONIC recently paired its Certified Clean program with Lucid Green Inc. and its revolutionary technology platform designed to provide vital safety information. Lucid Green’s technology provides a direct-to-consumer data platform, providing instant access to a library of product specific insights by simply scanning the package’s QR code with a smartphone camera.
Elite Brand Portfolio/Acquisitions
- IONIC, the company’s flagship recreational branded product, is a stylish and sophisticated premium vape pen line that has earned customer loyalty and a reputation as a consistent Top 10 vape brand in Washington state. IONIC’s immediate product line expansion plans include THC/CBD mixes, low-dose products, high-end edibles, CASK oil and device innovation.
- WW Agriculture cultivates cannabis outdoors on a 140-acre eastern Washington State farm capable of producing up to 100,000 pounds of cannabis for less than $0.10/gram.
- ZOOTS, a Washington-based edibles company, utilizes patent-protected ultra-clean CO2 extraction hardware to create proprietary formulations of refined cannabis oils and distillates. Through MedMen dispensaries, Zoots Edibles are currently available in Washington and Colorado and will soon be on shelves at dispensaries in Massachusetts, New York and Pennsylvania.
- Vuber Technologies hardware produces the best vaporization experience on the market.
- Vegas M Stick vaporizer pens are distributed to stores in Washington State with plans to expand to Oregon and Nevada.
- Vegas Valley Growers is a revenue-generating, vertically integrated operation in Las Vegas, Nevada, with a full complement of production, manufacturing and distribution licenses.
IONIC has also acquired two U.S. patents issued to Canna Café that are related to cannabinoid (CBD) infused coffee and CBD-infused coffee in a Keurig ® K-Cup ® Pod. An international patent is in process for cannabis-infused teas.
Experienced Management Team
IONIC Brands is led by an innovative product team, powerful sales organization and a world-class marketing group.
Chairman & CEO John Gorst has built and sold four different technology companies with market valuations in excess of $600 million. Gorst has been at the forefront of IONIC’s expansion and development into Washington state’s leading vaporizer brand.
Andrew Schell, President, Vice-Chairman & Co-Founder, has built several successful companies. Schell has an engineering background rounded in operations, strategy and corporate law, and most recently was CEO of a U.S. Department of Defense company specializing in military operations.
Christian Struzan, Chief Marketing Officer & Co-Founder, has over 30 years of experience in marketing and branding in the entertainment and consumer goods industries. Struzan founded an advertising agency which developed and executed marketing campaigns for feature films such as the Star Wars franchise, Fight Club, and the television series American Idol. He has also worked on global brands such as Guinness, Stella Artois and Beck’s.
Johnny Stange, Chief Revenue Officer, was formerly a director of sales for the southern California region for Treasury Wine Estates, a major wine wholesaler, where he grew and oversaw annual sales of $250 million. Stange is leading the charge in IONIC’s aggressive sales growth plans across multiple states.
In 2018, IONIC was voted one of the “Top 50 Companies to Work for in Cannabis” by MG Magazine, a publication serving cannabis industry professionals.
IONIC Brands Corp. (OTC: IONKF), closed Monday's trading session at $0.019, off by 5.00%, on 290,455 volume with 28 trades. The average volume for the last 3 months is 251,866 and the stock's 52-week low/high is $0.014999999/$0.634559988.
- Cannabidiol Can Help to Manage Endometriosis Pain, New Study
- 420 with CNW – What You Need to Know to Grow Marijuana in a Greenhouse
- CBD Dispensing Robots Installed in Colorado
Sugarmade, Inc. (SGMD)
Sugarmade (OTCQB: SGMD), a major supplier to the hydroponic cultivation and hemp sectors, today provided a strategic update as it advances plans to uplist to a major U.S. exchange while moving toward another targeted acquisition. According to the update, Sugarmade management expects the company to be on track to reach in excess of $65 million in annualized revenues based on its strategy. To view the full press release, visit http://cnw.fm/g39QJ.
Sugarmade, Inc. (SGMD), one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.
Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.
Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.
Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.
Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.
Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.
Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.
CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.
Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.
Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base. 6
Sugarmade, Inc. (SGMD), closed Monday's trading session at $0.0112, off by 21.6783%, on 3,2148,904 volume with 710 trades. The average volume for the last 3 months is 5,919,465 and the stock's 52-week low/high is $0.0073/$0.125.
- Sugarmade, Inc. (SGMD) Announces Ambitious Strategy as it Advances Plans to Uplist to Major US Exchange
- Two Cannabis Based Drugs Approved for Use in England
- Sugarmade, Inc. (SGMD) Releases H1 2019 Data for Recent BZRTH Acquisition Revealing Over $15M Sales, 25% Sequential Revenue Growth
SinglePoint, Inc. (SING)
SinglePoint Inc. (OTCQB: SING) subsidiary Direct Solar is surging in what was valued as a $52.5 billion global solar market in 2018 by Allied Market Research. Allied sees solar CAGR growing at 20.5 percent between 2019-2026, when it is expected to reach $233.3 billion (http://nnw.fm/Y208q). SING anticipates large growth and sustainability from Direct Solar, which it projects could deliver sales up to $25 million in FY2020, according to an interview by SinglePoint CEO Greg Lambrecht. Also today, the company was highlighted in a publication from HempWireNews, examining how more than 500 people have voiced their opinions on hemp rules less than two weeks after the USDA opened the public comment period.
SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.
SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.
SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:
- A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
- A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
- A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
- Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
- Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
- Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.
SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.
Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.
SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.
SinglePoint, Inc. (SING), closed Monday's trading session at $0.01075, off by 4.8673%, on 2,022,755 volume with 81 trades. The average volume for the last 3 months is 2,691,523 and the stock's 52-week low/high is $0.009999999/$0.028799999.
- SinglePoint Inc. (SING) Surging in $52.5 Billion Global Solar Market, Sees Solar Division Hitting $5 Million in Contracts by End of 2019
- 500 Comments About Federal Hemp Rules Already Submitted
- SinglePoint, Inc. (SING) CEO Discusses Substantially Increased Revenues and Profits on MoneyTV with Donald Baillargeon
LiveWire Ergogenics Inc. (OTC: LVVV)
LiveWire Ergogenics (OTC: LVVV), a forward-thinking company engaged in the acquisition, licensing and management of fully compliant turnkey facilities for the production of cannabis-based products and services in California, purchased an historic Paso Robles ranch property earlier this year (http://cnw.fm/QljG1).
LiveWire Ergogenics Inc. (OTC: LVVV) is a forward-thinking company specializing in identifying and monetizing current and future trends in the health and wellness industry. The company recognizes significant potential in the multibillion-dollar cannabis industry and operates at the forefront for acquisition and management of licensed cannabis real estate locations and the research, development and commercialization of high-end products for distribution throughout California.
During the past two years, LiveWire has diligently researched, secured, designed and set up several fully compliant and permitted cannabis operations in locations in California, including a state-wide distribution license from the Bureau of Cannabis Control. The company is focused on acquiring compliant real estate properties for cannabis operations and entering into operation agreements and strategic alliances to build teams of carefully selected and vetted operators, horticulturists, extractors, distributors and establish research partnerships. Its current portfolio of cannabis operations consists of the following properties:
PODs and Distribution in Coachella, California
For the past year, LiveWire has operated high-tech, state-of-the-art production structures, or “PODs” for its cannabis nursery business. Coachella is also home to the company’s statewide distribution headquarters. Both entities operate under LiveWire’s majority owned subsidiary, GHC Ventures. The company is currently in the process to strategically centralize all operations at its recently acquired Paso Robles facility, Estrella Ranch.
Estrella Ranch in Paso Robles, California
Through its subsidiary, Estrella Ranch Partners LLC, LiveWire acquired a 265-acre historic ranch property in Paso Robles, Calif. Estrella Ranch has a longstanding history, once owned by George R. Hearst, the eldest grandson of the late William Randolph Hearst, developer of Hearst Communications, and is considered among the finest ranches in California and the gem of the California Central Coast. LiveWire is transforming this property into the world’s first “Estate-Grown Weedery” with plans to develop it into a vertically integrated, high-end cannabis facility and wellness retreat in California. The stunning property, located in the heart of the world renown California wine country, currently houses three spacious residences, storage areas, and elaborate equestrian facilities with four barns and numerous stables. LiveWire is designing a truly unique property that features indoor and outdoor cannabis operations, including large outdoor and indoor cannabis production. Long-range plans include adding teaching and luxury recreational facilities focused on providing a comprehensive and unique cannabis-related retreat experience.
The Paso Robles Nursery
LiveWire has begun the build-out and will soon begin production in its 22,000-square-foot secure indoor cannabis nursery facility in Paso Robles, Calif. The project includes the conversion of two existing buildings with sufficient power capacity and abundant water supply. Floor plans include more than 10,000 square feet of canopy devoted to “mother” plants and separate clone storage; additional space has been identified for flowering plants. Within the two buildings, the nursery also contains research and development areas, rooms for cannabis waste and storage, record keeping and staging space, security offices, a conference room and additional designated locations required for permit approval and compliance.
LiveWire has spent significant resources to research and maneuver a complex legal environment and confirm the economic and environmental feasibility of potential LiveWire cannabis operations in different locations throughout the state of California. All LiveWire operations comply with California state law and local ordinances. To fully capitalize on these highly valuable assets, LiveWire is seeking funding to accelerate the development of its business plan.
GHC Ventures Subsidiary
GHC Ventures, LiveWire’s Coachella-based distribution division, employs a consumer-driven market approach that provides retailers access to a wide range of new high-end cannabis products, all serviced through the licensed and reliable GHC supply chain and distribution network.
GHC Ventures’ distribution network is available exclusively to licensed manufacturers that pass LiveWire’s stringent legal and environmental qualification process. This enables LiveWire to provide a large and solidly structured legal distribution network for all qualifying third-party operators in California. LiveWire is actively seeking to work with licensed operators who are enthusiastic and qualified to ensure the delivery of high-caliber and legal cannabis products for the fast-growing California medical and recreational cannabis markets.
LiveWire has established two independent research teams with world-renowned experts in their respective fields to pursue application of cannabis derivatives to specific targeted medical ailments. The company is also establishing research partnerships to explore the application of cannabinoid-based products to target specific ailments or conditions with large “sufferer” populations for both human and veterinarian applications. Possible applications may include dosing verification of zero-pesticide products for quality brands via its 7X Pure Cannabis Dosing and Verification System.
LiveWire has also engaged a highly qualified research team and advisory board to explore the opportunities in the unexplored yet highly valued equine space. The company has entered into consulting and/or advisory board agreements with high-caliber individuals from the medical and international-performance equine sector and is currently exploring strategic relationships with the veterinary departments of leading local and domestic universities and medical facilities.
7X Pure™ Dosing and Verification System
LiveWire Ergogenics is developing its “7X Pure Compliance and Dosage Verification System” intended to provide third-party verification of cannabis material origin, potency, purity, dosage and labeling, securing each product with a digital identity and clearly identifiable chain of custody.
The 7X Pure system will be completely secure, transparent and verifiable, protecting the confidentiality of growers’ and manufacturers’ intellectual property while providing retailers, consumers, government officials and others verification that the growers’ and manufacturers’ claims are true.
The system is designed as a parallel service to the seed-to-sale data provided by marijuana tracking software, will help growers and manufacturers meet increasing compliance requirements related to logistics, quality and transparency. It will also provide a high level of assurance to everyone from end users to municipalities.
Acquisitions & Operations
To maximize the utilization of its fully compliant locations and the licenses granted throughout California, LiveWire has begun and continues to pursue acquisitions of and/or strategic alliances with qualified cannabis companies and consultants. LiveWire will apply a strict regimen to the acquisition of operators, carefully utilizing its experience and legal standing in the California cannabis market for the selection of qualified operators.
Legal marijuana is the fastest-growing industry in the United States. Twenty-nine states have already legalized medical marijuana, eight states have approved it for recreational use, and more are following suit. Once the trend toward legalization expands to all 50 states, marijuana could become larger than the organic food industry, according to a new report obtained by The Huffington Post.
The U.S. marijuana industry is forecast to generate annual revenues ranging from $17 billion to $35 billion by 2021. The combined legal medical and recreational market has grown by roughly 30 percent, reaching $6 billion during 2017, according to The Marijuana Business Factbook. The same study projects the market will increase 300 percent to top $17 billion by 2021. During 2017 recreational sales grew by 80 percent, reaching $1.8 billion, not yet accounting for sales of the biggest revenue producer, California, which will only commence with recreational sales in 2018.
LiveWire’s diligent approach to the cannabis sector is based on extensive environmental and legal research to predetermine the feasibility of the locations it selects for operations. The company pursues a carefully selected approach of acquiring, licensing and managing self-contained and permitted real estate properties for the development and distribution of its products and leasing to third party operators. LiveWire avoids the complications and high start-up cost of the typical large “growing” operations, instead focusing on becoming the market leader in research, cloning and verification, producing and distributing high quality brands.
LiveWire’s team of experienced corporate managers and innovators are leading the company’s plans to capture increasing market share from different and often underserved market sectors in the cannabis industry. LiveWire intends to utilize its team’s experience to accelerate the development and/or acquisition of new properties, product offerings, and companies.
Bill Hodson, CEO & Chairman of the Board
Bill Hodson is responsible for the strategic direction of the firm’s development, branding, sales and marketing strategies. In addition to being responsible for the operation of the company, he leads the development and manages implementation of the company’s innovative product strategy. Previously the executive vice president of LiveWire Sports Group, Hodson was responsible for overseeing all LiveWire’s operations, including the launch of several sports publications and one of the country’s largest sports consumer expos.
As early as five years ago, Hodson recognized the potential of CBD and became an early adopter of CBD as a health and wellness supplement by including hemp-derived cannabidiol in a starburst size edible product. His experience includes not only product development, marketing and sales, but most significantly constant city and county advocacy, guiding the company through four license processes, identifying and spearheading real estate acquisitions, and to assemble operations teams comprised of nursery horticulturists, cultivators and distribution personnel. His vision for the industry is complimented with his out-of-the-box thinking and anticipation of positioning for the future.
Kyle McKay, Horticulturist
Kyle McKay is responsible for managing LiveWire’s controlled cultivation environment, developing new-age genetics to produce consistent and high-quality products for medical patients, and applying his expertise in integrated pest management with Omri-certified fungicides and pesticides. McKay oversees the company’s clone development and supervises both cultivation facilities in Coachella and Paso Robles. He also assists with location research and selection; cultivation center planning; operations set-up; and maximizing the growth potential of cannabis edibles, concentrates and oil production. McKay’s expertise in plant genetics and modern horticulture technology makes him extremely qualified to guide LiveWire’s efforts. During his 12-plus years in the cannabis horticulture field, he has grown more than 230 stable genetics, managed over 27 cultivation centers and grown the specific strains required to meet the needs of up to 45,000 medical cannabis patients at one time.
Jeff Halloran, Investment Banker
Jeff Halloran is an accomplished senior-management executive with more than 35 years of experience. He has founded and held top positions in large financial and technology firms and has an outstanding record of achievement managing multimillion and billion-dollar programs. Halloran will use his standing in the Canadian markets to provide LiveWire with research and advice for potential acquisitions and strategic alliance targets in the burgeoning Canadian cannabis markets. Halloran has spent most of his career in leading management and consulting positions gathering extensive knowledge in strategic business analysis and information management theories. He served as managing director of Avalon Capital and Halloran Investment, as well as chairman and/or CEO of several companies owned by MT Dynamics. As a consulting manager he was recruited by Oracle Corporation to establish the multibillion-dollar organization’s consulting practice in Canada, eventually earning a place on the design team for Oracle Financials and its CASE Tool and Methodology. Halloran also heads up the executive committee for the Willow Breast Cancer Support Organization.
Michael Corrigan, Attorney at Law
Michael Corrigan is a legal professional at the Law Offices of Michael L. Corrigan, practicing in San Diego, Calif. His practice emphasizes general and SEC representation of emerging high-technology and other operating companies. He has been counsel to private and public companies in a broad range of industries, including computer hardware and software, telecommunications, multimedia and cannabis.
Matthew Geriak, Clinical Pharmacist and Investigational Research Pharmacist
Matthew Geriak is a specialized pharmacist and has a system-wide position on the Investigational Review Board for Sharp Healthcare, which owns five hospitals and various clinics throughout San Diego County. Sharp conducts drug research spanning from phase 1 to 4 human research clinical trials focusing on the fields of oncology, renal and heart transplantations, septic shock treatment, infectious diseases and anticoagulation. Geriak is the primary investigator for retrospective cohorts in the field of infectious diseases.
Jimmy Connors, Sports Industry Adviser
Jimmy Connors is a legendary No. 1 ranked tennis player and is considered among the greatest in the history of the sport. Today, Connors still holds three prominent Open Era Men’s singles records: 109 titles, 1,535 matches played, and 1,256 matches won. His titles include eight?majors, five U.S. Opens, two Wimbledons, one Australian Open, three year-end championships and 17?Grand Prix Super Series. Connors brings a wealth of knowledge in the sports and wellness industries that will be especially important as LiveWire expands into its next phase of development with its topical products. His decade-long exposure in the global sports world as one of the most recognized personalities adds a high level of exposure and supports LiveWire’s efforts to set itself apart in a fast-growing and still turbulent and disruptive industry.
LiveWire Ergogenics Inc. (OTC: LVVV), closed Monday's trading session at $0.0045, off by 7.9755%, on 1,708,046 volume with 24 trades. The average volume for the last 3 months is 1,190,886 and the stock's 52-week low/high is $0.0038/$0.037399999.
- LiveWire Ergogenics Inc. (LVVV) Announces Financial Report for Q3 2019
- LiveWire Ergogenics Inc. (LVVV) Transforming Historic Paso Robles Ranch Property Into High-End Cannabis Facility and Wellness Retreat
- Thousand Oaks City Council Extends Hemp Moratorium Till September 2020
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- B2Digital Inc. (BTDG) Secures Fully Reporting Status with SEC
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Announces Launch of “Talking Tom and Friends” Bouncing Bubble in China
- Cannabis Strategic Ventures, Inc. (OTCQB: NUGS) Comments on Recent Unauthorized Promotional Activity in Response to OTC Markets Request
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Reports Q2 Fiscal Year 2020 Financial Results, Provides Corporate Update
- ChineseInvestors.com (CIIX) to Focus on Core Business, Hemp-Infused/CBD Products in 2020
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) to Acquire 19.9% Equity Interest of Coastal Green, a BC-Based Cannabis Retailer
- City View Green (CSE: CVGR) (OTCQB: LRZZF) Puts Cultivation on Hold to Focus on Extraction, Edibles and Distribution
- CloudCommerce (OTCQB: CLWD) Benefiting from Dramatic Transition to Digital Advertising
- Dama Financial - Enters Strategic Partnership with PayWana
- Endonovo Therapeutics (OTCQB: ENDV) SofPulse(R) Reduces Opioid Prescriptions at New Hanover Regional Medical Center
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Frost & Sullivan Begins Coverage of Foresight Autonomous Holdings (FRSX): A Game Changing Company Targeting Autonomous Vehicles
- Genprex, Inc. (NASDAQ: GNPX) Issues Lung Cancer Prevention Measures in Support of Lung Cancer Awareness Month
- GP Solutions (GWPD) Announces Launch of “Prolific Soilless Growth Medium” and “Prolific Hydro” on Amazon
- Grapefruit Boulevard Investments Inc. (IGNG) Can CBD Help Cure Hangovers?
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) 420 with CNW – Yale Teams Up With Weed Company to Study Effects of Cannabis on Stress
- Green Hygienics Holdings Inc. (OTC: GRYN) 420 with CNW – What You Need to Know to Grow Marijuana in a Greenhouse
- Hemptown USA - Bullish on Potential of a Relatively Unknown Cannabinoid — CBG
- HTC Extraction Systems (TSX.V: HTC) Hemp Biomass Extraction Facilities Take Shape
- InsuraGuest Inc. - Provides First Line of Defense for Vacation Rental Industry and Guests
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) 420 with CNW – What You Need to Know to Grow Marijuana in a Greenhouse
- Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) Appoints Strategic Advisor, Advances Tech Platform as Alternative to Smoking and Vaping
- LiveWire Ergogenics Inc. (OTC: LVVV) Thousand Oaks City Council Extends Hemp Moratorium Till September 2020
- Marijuana Company of America Inc. (MCOA) 420 with CNW – Clinical Trials of Cannabis as a Treatment for Pancreatic Cancer Expected
- MCTC Holdings Inc. (MCTC) Why MCTC is “One to Watch”
- MustGrow Biologics Corp (CSE: MGRO) Intends to Tackle New Fusarium Pathogen Threatening Worldwide Banana Supply
- Neutra Corp. (OTCQB: NTRR) How the National Hemp Rules Could Affect Idaho
- Nightfood, Inc. (OTCQB: NGTF) Presenting at Today’s “Next Super Stock Live!” Online Investor Conference Hosted by Wall Street Reporter
- Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) Bill Filed in Illinois to Give Marijuana Industry Greater Access to Banking Services
- ORHub Inc. (ORHB) Settles Litigation with Former Chief Financial Officer
- OriginClear (OCLND) Sees Major Opportunity as the Permian Basin Experiences Water Shortage
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Announces Successful Completion of Phase 1 Nickel/Cobalt Process Recovery Program
- Pacific Software, Inc. (PFSF) Collaborates with Império for Commercial Marketing and Promotion of BOAPIN.com Trade Portal
- Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Announces Anticipated Automation Completion Date
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Appoints First-Ever Chief Scientific Officer
- Predictive Oncology Inc. (NASDAQ: POAI) Harnessing the Power of Artificial Intelligence to Improve Clinical Outcomes
- Pressure BioSciences Inc. (PBIO) PCT Platform Highlighted at IGCS Conference in Brazil
- Quest Patent Research Corp. (QPRC) Maintains Robust Portfolio of Diverse IP Assets
- Sharing Services Global Corporation (SHRG) Achieves Record Revenues During Q1 2019
- Sigma Labs, Inc. (NASDAQ: SGLB) Posts Q3 2019 Financial Results
- SinglePoint, Inc. (SING) CEO Discusses Substantially Increased Revenues and Profits on MoneyTV with Donald Baillargeon
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Integrates with CrisisGo to Bring Nation’s Yellow School Bus Drivers an Instant Emergency Communications Solution
- Spectrum Global Solutions, Inc. (SGSI) Set to Profit as 5G Rollout Nears
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) 420 with CNW – Clinical Trials of Cannabis as a Treatment for Pancreatic Cancer Expected
- SRAX Inc. (NASDAQ: SRAX) Reports Q3 2019 Vertical Sales Increase 17% Year-over-Year and Net Income of $1.4 Million
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) CEO to Participate in Two Upcoming Industry Conferences
- Sugarmade, Inc. (SGMD) Two Cannabis Based Drugs Approved for Use in England
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Announces Q1 2020 Results, $90 Million Credit Facility led by Bank of Montreal
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Releases Q3 2019 Results
- Trxade Group Inc. (TRXD) Bonum Health Unveils Next-Gen Healthcare Solution Coming Soon to Independent Pharmacies
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) Reports Third Quarter 2019 Results
- VPR Brands, LP (VPRB) How the National Hemp Rules Could Affect Idaho
- Willow Biosciences Inc. (CSE: WLLW) Announces Plans to Participate in Cowen 2nd Annual Boston Cannabis Conference
- Wonderfilm Media (TSX.V: WNDR) (OTCQB: WDRFF) Latest Theatrical Premiere Features Steven Seagal, DMX and Johnny Messner in “BEYOND THE LAW”
- Xalles Holdings Inc. (XALL) Offering Solutions in E-Commerce, Payments, Financial Reconciliation Sectors
- Youngevity International, Inc. (NASDAQ: YGYI) Postpones Third Quarter and Nine-Month Results Conference Call
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.